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INTRODUCTION	  Breast	  cancer	  is	  the	  second	  leading	  cause	  of	  cancer	  death	  in	  women	  after	  lung	  cancer,	  and	  is	  currently	  the	  most	  common	  form	  of	  cancer	  in	  women	  other	  than	  skin	  cancer	  in	  the	  United	  States	  (ACS,	  2013).	  	  In	  the	  United	  States	  in	  2013,	  a	  total	  of	  232,340	  new	  breast	  cancer	  cases	  and	  39,620	  new	  breast	  cancer	  deaths	  are	  projected	  to	  occur	  in	  women	  (Siegel	  et	  al.,	  2013).	  	  Surgery,	  chemotherapy,	  radiation,	  and	  hormone	  replacement	  therapies	  are	  the	  most	  commonly	  used	  treatments	  for	  those	  with	  cancer	  (ACS,	  2013).	  	  Treatment	  improvements	  and	  early	  diagnosis	  have	  increased	  survival	  rates,	  and	  more	  women	  are	  surviving	  longer	  than	  ever	  before.	  	  There	  have	  also	  been	  other	  factors	  contributing	  to	  the	  increased	  survival	  rate	  of	  cancer	  patients	  such	  as	  a	  higher	  awareness	  of	  the	  importance	  of	  self-­‐examination,	  greater	  education,	  and	  advancements	  in	  modern	  technology	  (ACS,	  2013).	  	  	  Breast	  cancer	  treatment	  results	  in	  many	  negative	  side	  effects.	  	  These	  include	  fatigue,	  nausea,	  pain,	  muscle	  weakness,	  and	  loss	  of	  functional	  capacities	  among	  others.	  	  In	  addition,	  cancer	  treatment	  has	  been	  shown	  to	  result	  in	  inflammation	  along	  with	  decreased	  immune	  system	  function	  (Battaglini	  et	  al.,	  2006;	  Grivennikov	  et	  al.,	  2010).	  	  Exercise	  has	  been	  shown	  to	  be	  an	  effective	  method	  for	  alleviating	  some	  of	  these	  side	  effects	  of	  cancer	  treatment	  (Schmitz	  et	  al.,	  2010).	  	  Improvements	  in	  cardiorespiratory	  and	  muscular	  fitness,	  and	  overall	  quality	  of	  life	  along	  with	  reductions	  in	  fatigue,	  nausea,	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and	  pain	  have	  been	  well	  documented	  in	  the	  literature	  (Dimeo	  et	  al.,	  1997;	  Herrero	  et	  al.,	  2005;	  Kim	  et	  al.,	  2006;	  Battaglini	  et	  al.,	  2006;	  De	  Backer	  et	  al.,	  2008;	  Hayes	  et	  al.,	  2012;	  Cormie	  et	  al.,	  2013).	  Most	  recently,	  one	  of	  the	  areas	  that	  has	  sparked	  interest	  among	  researchers	  in	  exercise	  oncology	  is	  the	  effect	  of	  exercise	  on	  markers	  of	  inflammation	  (Cytokines)	  and	  immune	  response.	  	  One	  of	  the	  main	  reasons	  for	  the	  increased	  interest	  in	  this	  area	  of	  research	  is	  due	  to	  the	  important	  roles	  cytokines	  have	  in	  immune	  response.	  	  These	  roles	  include:	  coordination	  of	  inflammatory	  responses	  which	  permits	  communication	  between	  immune	  cells,	  immune	  regulation	  through	  interactions	  with	  specific	  membrane	  receptors,	  and	  activation	  of	  intracellular	  signaling	  transduction	  pathways	  to	  induce	  gene	  transcription	  and	  synthesis	  of	  new	  cellular	  proteins	  (Chaplin,	  2010;	  Zhou,	  2010).	  	  Cytokines	  are	  also	  mediators	  of	  innate	  and	  adaptive	  immunity,	  and	  are	  often	  involved	  in	  inflammation	  through	  their	  effects	  on	  cell	  recruitment,	  cell	  activation,	  and	  antigen	  presentation	  (Zhou,	  2010).	  	  Cytokines	  have	  been	  shown	  to	  mediate	  the	  proliferative	  and	  cytolytic	  activities	  of	  different	  cell	  types	  that	  target	  malignant	  cells	  such	  as	  NK	  cells,	  cytotoxic	  T	  cells,	  and	  monocytes	  (Abbas,	  2005).	  	  There	  is	  preliminary	  evidence	  that	  populations	  with	  moderate	  to	  high	  levels	  of	  inflammatory	  markers	  may	  reduce	  circulating	  levels	  of	  pro-­‐inflammatory	  cytokines	  with	  regular	  aerobic	  exercise	  (Petersen	  and	  Pedersen,	  2006).	  	  However,	  studies	  that	  have	  investigated	  the	  exercise-­‐induced	  inflammatory	  and	  immune	  response	  in	  breast	  cancer	  survivors	  are	  scarce	  and	  have	  presented	  conflicting	  results,	  with	  some	  showing	  positive	  exercise	  effects	  while	  others	  showing	  no	  response	  (Pederson,	  2000;	  Löf	  et	  al.,	  2012).	  	  Possible	  explanations	  for	  the	  variable	  results	  in	  the	  inflammatory	  and	  immune	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response	  presented	  in	  the	  current	  literature	  may	  be	  due	  to	  different	  study	  populations,	  different	  types	  of	  anti-­‐cancer	  treatment,	  and	  the	  type,	  intensity,	  and	  duration	  of	  the	  exercise.	  	  In	  addition,	  the	  sensitivity	  of	  the	  assays	  used	  in	  different	  studies	  can	  affect	  the	  cytokine	  profile	  (Pederson,	  2000).	  	  	  	  An	  interesting	  observation	  when	  examining	  the	  current	  literature	  regarding	  the	  effects	  of	  exercise	  on	  cytokines	  and	  immune	  marker	  responses	  in	  cancer	  patients	  is	  that	  all	  previous	  studies	  have	  only	  examined	  the	  immune	  and	  inflammatory	  marker	  responses	  in	  relation	  to	  chronic	  exercise;	  in	  other	  words,	  these	  studies	  had	  cancer	  patients	  exercise	  train	  for	  a	  period	  of	  time,	  and	  cytokines	  and	  inflammatory	  markers	  were	  assessed	  at	  baseline	  and	  follow-­‐up	  (prior	  to	  training	  and	  at	  the	  end	  of	  the	  exercise	  training	  period)	  (Fairey	  et	  al.,	  2005a;	  Hutnick	  et	  al.,	  2005;	  Gomez	  et	  al.,	  2011;	  Janelsins	  et	  al.,	  2011;	  Jones	  et	  al.,	  2012).	  The	  focus	  of	  these	  studies	  was	  to	  examine	  the	  effects	  of	  exercise	  training	  interventions	  on	  potential	  up-­‐regulation	  of	  immune	  function	  through	  mediation	  of	  positive	  changes	  in	  inflammatory	  markers	  (é	  anti-­‐inflammation	  while	  ê	  pro-­‐inflammatory	  markers)	  (Fairey	  et	  al.,	  2005a;	  Peterson	  and	  Pedersen,	  2005).	  	  	  In	  cancer	  survivors,	  the	  potential	  positive	  mediation	  of	  cytokine	  response	  to	  exercise	  training	  on	  the	  up-­‐regulation	  of	  immune	  function	  may	  translate	  into	  better	  immune	  surveillance	  and	  therefore	  a	  potential	  risk	  reduction	  of	  a	  possible	  recurrence	  and	  ultimately	  longer	  survival.	  	  It	  is	  also	  important	  to	  note	  that	  repeated	  bouts	  of	  acute	  high	  intensity/long	  duration	  exercise	  without	  sufficient	  recovery	  has	  been	  suggested	  to	  further	  suppress	  the	  immune	  system	  and	  lead	  to	  chronic	  impairments	  in	  immune	  function	  (Smith,	  2003).	  	  For	  cancer	  survivors,	  an	  immune	  suppressed	  state	  could	  promote	  an	  undesirable	  long-­‐term	  prognosis.	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Cancer	  treatments	  may	  often	  have	  considerable	  effects	  on	  the	  immune	  system	  of	  cancer	  patients	  and	  survivors,	  particularly	  by	  decreasing	  cell	  number	  and	  function	  of	  immune	  cells	  including	  components	  that	  are	  associated	  with	  anti-­‐cancer	  defense	  (NK	  Cells,	  neutrophils,	  macrophages,	  and	  T	  lymphocytes)	  (Fairey	  et	  al.,	  2002).	  In	  order	  to	  better	  understand	  how	  these	  treatments	  impact	  immune	  function	  and	  perhaps	  how	  exercise	  may	  alter	  the	  immune	  system	  in	  cancer	  patients,	  it	  is	  paramount	  that	  the	  examination	  of	  an	  acute	  bout	  of	  exercise	  on	  the	  immune	  response	  in	  cancer	  patients	  is	  investigated.	  	  Examining	  the	  acute	  effects	  of	  an	  exercise	  bout	  on	  markers	  of	  inflammation	  and	  immune	  function	  in	  this	  population	  will	  allow	  for	  a	  better	  understanding	  of	  the	  effect	  of	  exercise	  on	  the	  immune	  response	  of	  cancer	  patients	  and	  the	  role	  of	  inflammation	  in	  the	  regulation	  of	  immune	  function.	  	  This	  will	  also	  help	  identify	  the	  immune	  system	  recovery	  throughout	  the	  exercise	  timeline	  so	  more	  precise	  exercise	  prescriptions	  in	  regards	  to	  intensity,	  volume,	  and	  frequency	  of	  exercise	  training	  can	  be	  devised	  for	  cancer	  patients.	  	  Studying	  these	  effects	  can	  help	  provide	  certainty	  for	  promoting	  positive	  immune	  adaptations	  while	  avoiding	  the	  potential	  of	  exercise	  to	  create	  an	  immune	  suppression	  response	  in	  this	  population.	  The	  majority	  of	  breast	  cancer	  survivors	  have	  been	  shown	  to	  have	  higher	  levels	  of	  inflammation	  compared	  to	  healthy	  populations	  (Seruga	  et	  al.,	  2008).	  	  Exercise	  prescriptions	  for	  breast	  cancer	  survivors	  are	  designed	  after	  those	  for	  healthy	  populations,	  but	  it	  is	  currently	  unknown	  whether	  breast	  cancer	  survivors	  have	  similar	  exercise-­‐induced	  inflammatory	  responses	  as	  healthy	  individuals	  (Schmitz	  et	  al.,	  2010).	  	  Therefore,	  it	  is	  necessary	  to	  examine	  the	  inflammatory	  response	  to	  an	  acute	  bout	  of	  exercise	  in	  order	  to	  compare	  the	  inflammatory/immune	  response	  during	  and	  post-­‐
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completion	  of	  an	  exercise	  bout	  (recovery	  from	  exercise)	  so	  comprehensible	  exercise	  prescription	  guidelines	  for	  breast	  cancer	  survivors	  can	  be	  designed	  to	  be	  safer	  and	  promote	  optimal	  benefits	  while	  minimizing	  the	  potential	  issue	  of	  promoting	  immune	  suppression.	  In	  a	  previous	  dissertation,	  Dr.	  Elizabeth	  Evans	  evaluated	  the	  immune	  response	  to	  an	  acute	  bout	  of	  exercise	  in	  breast	  cancer	  survivors	  and	  healthy	  controls.	  	  The	  current	  study	  is	  retrospective	  in	  nature,	  and	  will	  use	  stored	  blood	  samples	  from	  Dr.	  Evans’	  dissertation	  to	  examine	  the	  inflammatory	  response	  between	  breast	  cancer	  survivors	  and	  healthy	  controls	  during	  one	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise.	  	  With	  the	  goal	  of	  researching	  the	  pro	  and	  anti-­‐inflammatory	  response,	  Tumor	  Necrosis	  Factor	  (TNF-­‐α),	  C-­‐Reactive	  Protein	  (CRP),	  and	  Interleukin	  10	  (IL-­‐10)	  were	  the	  inflammatory	  markers	  selected	  for	  the	  current	  study.	  	  These	  markers	  were	  also	  selected	  because	  they	  are	  commonly	  seen	  in	  research	  examining	  this	  population.	  	  NK	  cell	  count	  has	  already	  been	  measured	  in	  the	  previous	  dissertation	  of	  Dr.	  Evans.	  	  NK	  cells	  are	  highly	  associated	  with	  tumor	  progression,	  and	  they	  were	  selected	  for	  correlational	  purposes	  in	  order	  to	  investigate	  if	  inflammatory	  markers	  can	  potentially	  modulate	  immune	  function	  due	  to	  exercise	  in	  breast	  cancer	  survivors.	  	  Statement	  of	  the	  purpose	  The	  purpose	  of	  this	  study	  was	  to	  investigate	  the	  effect	  of	  one	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise	  on	  selected	  markers	  of	  inflammation	  in	  post-­‐treatment	  breast	  cancer	  survivors.	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A	  secondary	  purpose	  was	  to	  examine	  the	  relationship	  between	  selected	  markers	  of	  inflammation	  and	  natural	  killer	  cell	  count	  to	  explore	  if	  the	  potential	  mediation	  of	  the	  immune	  response	  was	  also	  influenced	  by	  the	  inflammatory	  response	  due	  to	  exercise	  in	  breast	  cancer	  survivors.	  	  Research	  questions	  R1.	  	  Does	  one	  bout	  of	  acute	  aerobic	  exercise	  alter	  the	  inflammatory	  response	  in	  breast	  cancer	  survivors	  and	  healthy	  controls	  immediately	  post-­‐exercise?	  R2.	  	  How	  long	  does	  the	  inflammatory	  response	  to	  an	  acute	  bout	  of	  exercise	  last	  in	  both	  the	  breast	  cancer	  and	  healthy	  control	  groups?	  R3.	  	  Does	  the	  inflammatory	  response	  due	  to	  exercise	  in	  breast	  cancer	  survivors	  differ	  from	  healthy	  controls?	  R4.	  	  Is	  there	  a	  relationship	  between	  the	  changes	  in	  inflammatory	  markers	  and	  the	  change	  in	  NK	  cell	  count	  after	  an	  acute	  bout	  of	  aerobic	  exercise	  in	  breast	  cancer	  survivors?	  	  Hypotheses	  H1:	  	  From	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  both	  TNF-­‐α	  and	  CRP	  will	  be	  significantly	  reduced	  in	  both	  groups.	  	   H1a:	  	  From	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  IL-­‐10	  will	  be	  	   significantly	  increased	  in	  both	  groups.	  H2:	  	  From	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  both	  TNF-­‐α	  and	  CRP	  will	  be	  significantly	  reduced	  in	  both	  groups.	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   H2a:	  	  From	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  IL-­‐10	  will	  be	  significantly	  	   increased	  in	  both	  groups.	  H3:	  	  From	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  both	  TNF-­‐α	  and	  CRP	  will	  be	  significantly	  reduced	  in	  both	  groups.	  	   H3a:	  	  From	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  IL-­‐10	  will	  be	  significantly	  	   increased	  in	  both	  groups.	  H4:	  	  There	  will	  be	  a	  significant	  inverse	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  both	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  both	  groups.	  H4a:	  	  There	  will	  be	  a	  significant	  inverse	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  both	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  groups.	  H4b:	  	  There	  will	  be	  a	  significant	  inverse	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  both	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  groups.	  H5:	  	  There	  will	  be	  a	  significant	  positive	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  both	  groups.	  H5a:	  There	  will	  be	  a	  significant	  positive	  correlation	  between	  changes	  in	  NK	  cell	  	   count	  and	  changes	  in	  IL-­‐10	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  	   groups.	  H5b:	  	  There	  will	  be	  a	  significant	  positive	  correlation	  between	  changes	  in	  NK	  cell	  	   count	  and	  changes	  in	  IL-­‐10	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  	   groups.	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Operational	  definitions	  
• Major	  Cancer	  Treatment:	  Surgery,	  chemotherapy,	  and	  radiation	  therapy.	  
• Breast	  Cancer	  Survivors:	  Women	  between	  the	  ages	  of	  40-­‐70	  years	  who	  had	  confirmed	  diagnosis	  of	  Stages	  I-­‐III	  invasive	  breast	  cancer	  and	  had	  completed	  all	  planned	  surgery,	  radiation	  therapy,	  and	  chemotherapy	  3-­‐6	  months	  prior	  to	  participation	  in	  the	  study.	  
• Healthy	  Controls:	  	  Study	  group	  which	  included	  women	  40-­‐70	  years	  of	  age	  who	  were	  healthy,	  sedentary,	  and	  had	  never	  received	  treatment	  for	  cancer	  of	  any	  type.	  Healthy	  controls	  were	  matched	  to	  breast	  cancer	  survivors	  based	  on	  age.	  
• Sedentary:	  	  Not	  participating	  in	  regular	  physical	  activity	  for	  at	  least	  1	  year	  prior	  to	  enrollment	  in	  the	  study.	  Regular	  physical	  activity	  would	  be	  considered	  as	  30-­‐minutes	  of	  moderate-­‐vigorous	  activity,	  3	  days	  per	  week.	  
• VO2peak:	  	  A	  subject’s	  peak	  aerobic	  capacity,	  measured	  during	  a	  maximal	  cardiopulmonary	  exercise	  test	  (CPET).	  
• Acute	  Bout	  of	  Intermittent	  Exercise:	  	  The 30-minute exercise bout was comprised of ten 
3-minute exercise intervals performed at 60%	  of	  VO2peak alternating with 1.5 minutes of 
rest.  A discontinuous exercise protocol was used to ensure that all subjects would be 
capable of completing the exercise session.	  
• Baseline:	  	  The	  study	  time	  point	  that	  will	  occur	  immediately	  before	  commencing	  the	  acute	  bout	  of	  moderate	  intensity	  exercise.	  Baseline	  is	  synonymous	  with	  pre-­‐exercise.	  	  
• Immediately	  post-­‐exercise:	  	  The	  study	  time	  point	  that	  occurred	  immediately	  upon	  completion	  of	  the	  acute	  bout	  of	  moderate	  intensity	  exercise.	  	  
	   9	  
• 2	  hours	  post-­‐exercise:	  	  The	  study	  time	  point	  that	  occurred	  2	  hours	  after	  completion	  of	  the	  acute	  bout	  of	  moderate	  intensity	  exercise.	  
• 24	  hours	  post-­‐exercise:	  	  The	  study	  time	  point	  that	  occurred	  24	  hours	  after	  completion	  of	  the	  acute	  bout	  of	  moderate	  intensity	  exercise.	  
• Innate	  immune	  system:	  The	  initial	  host	  response	  due	  to	  the	  broad	  number	  of	  recognition	  molecules	  that	  act	  rapidly	  after	  an	  invading	  pathogen	  or	  toxin	  is	  encountered	  (Chaplin,	  2010;	  Seruga	  et	  al.,	  2008).	  	  	  
• Inflammation:	  A	  complex	  reaction	  of	  the	  innate	  immune	  system	  in	  tissues	  involving	  the	  accumulation	  and	  activation	  of	  plasma	  proteins	  and	  leukocytes	  at	  a	  site	  of	  cell	  injury,	  toxin	  exposure,	  or	  infection	  (Abbas,	  2005).	  	  
• NK	  cells:	  Major	  cellular	  components	  of	  the	  innate	  immune	  response	  that	  attack	  virally	  infected	  cells	  as	  well	  as	  tumor	  cells	  (Abbas,	  2005).	  	  	  
• Cytokines:	  Proteins	  produced	  by	  macrophages	  and	  many	  other	  types	  of	  innate	  immune	  system	  cells	  in	  response	  to	  microbes	  and	  other	  antigens	  that	  mediate	  inflammatory	  and	  immune	  reactions	  (Abbas,	  2005).	  They	  help	  control	  various	  aspects	  of	  cellular	  growth	  and	  differentiation	  (Corwin,	  2000)	  	  	  	  
• C-­‐reactive	  protein:	  An	  acute	  phase	  protein	  produced	  in	  the	  liver	  that	  has	  pro-­‐inflammatory	  characteristics	  and	  is	  a	  highly	  significant	  marker	  of	  inflammatory	  disease	  (Abbas,	  2005).	  	  
• TNF-­‐α:	  A	  pro-­‐inflammatory	  cytokine	  that	  is	  responsible	  for	  many	  of	  the	  systemic	  complications	  of	  severe	  infections.	  	  TNF-­‐α	  is	  also	  an	  important	  mediator	  of	  the	  acute	  inflammatory	  response	  to	  infectious	  microbes	  (Abbas,	  2005).	  
• IL-­‐10:	  Produced	  by	  T	  cells	  and	  is	  an	  inhibitor	  of	  host	  immune	  responses,	  especially	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those	  involving	  macrophages	  (Corwin,	  2000).	  IL-­‐10	  has	  anti-­‐inflammatory	  properties	  and	  is	  considered	  the	  most	  profound	  immunosuppressive	  cytokine	  (Smith,	  2003).	  	  Delimitations	  
• All	  subjects	  were	  women	  between	  the	  ages	  of	  40	  and	  70	  years	  old.	  
• All	  subjects	   in	   the	  breast	  cancer	  survivor	  group	  had	  completed	   their	  major	  cancer	  treatments	  and	  surgeries	  3-­‐6	  months	  prior	  to	  the	  time	  of	  participation	  in	  the	  study.	  
• All	  subjects	  in	  the	  control	  group	  had	  been	  sedentary	  for	  at	  least	  1	  year	  prior	  to	  enrollment;	  i.e.,	  they	  had	  not	  participated	  in	  regular	  organized	  physical	  activity	  within	  the	  past	  year.	  
• 	  	  	  Subjects	  in	  the	  breast	  cancer	  survivor	  group	  were	  recruited	  from	  the	  Medical	  Oncology	  clinic	  and	  the	  Radiation	  Oncology	  clinic	  at	  the	  NC	  Cancer	  Hospital	  on	  the	  campus	  of	  the	  University	  of	  North	  Carolina	  at	  Chapel	  Hill	  (UNC-­‐Chapel	  Hill)	  as	  well	  as	  from	  the	  waitlist	  of	  the	  Get	  REAL	  and	  HEEL	  Breast	  Cancer	  Program	  in	  the	  Department	  of	  Exercise	  and	  Sport	  Science	  at	  UNC-­‐Chapel	  Hill.	  	  
• 	  	  	  Subjects	  in	  the	  healthy	  control	  group	  were	  recruited	  from	  the	  faculty,	  staff,	  and	  student	  populations	  at	  UNC-­‐Chapel	  Hill,	  as	  well	  as	  from	  across	  the	  Triangle	  region	  of	  North	  Carolina.	  	  
• 	  	  	  Baseline	  study	  time	  points	  occurred	  between	  7:00-­‐10:00am	  in	  order	  to	  control	  for	  daily	  variations	  in	  study	  variables.	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• All	  the	  subjects	  were	  cleared	  by	  their	  medical	  oncologist	  or	  primary	  physician	  prior	  to	  enrolling	  in	  the	  study,	  and	  had	  no	  major	  health	  issues	  that	  precluded	  their	  ability	  to	  engage	  in	  low	  to	  moderate	  exercise	  training.	  
• 	  	  	  Before	  the	  VO2peak	  assessment	  and	  the	  acute	  bout	  of	  exercise,	  subjects	  were	  asked	  to	  refrain	  from	  eating	  2	  hours	  prior	  to	  testing	  and	  not	  to	  exercise	  for	  at	  least	  12	  hours	  prior	  to	  testing.	  	  Also,	  subjects	  were	  asked	  to	  refrain	  from	  caffeine	  use	  at	  least	  12	  hours	  prior	  to	  testing	  and	  not	  consume	  alcohol	  at	  least	  48	  hours	  prior	  to	  testing.	  	  	  Assumptions	  
• All	  breast	  cancer	  survivors	  strictly	  adhered	  to	  all	  of	  the	  pre-­‐assessment	  guidelines	  given	  to	  them	  prior	  to	  reporting	  to	  all	  laboratory-­‐testing	  sessions.	  	  
• The	  impact	  of	  different	  cancer	  treatments	  and	  drugs	  would	  result	  in	  similar	  side	  effects	  experienced	  by	  the	  subjects	  in	  the	  breast	  cancer	  survivor	  group.	  
• All	  subjects	  accurately	  reported	  medical	  history,	  and	  abstained	  from	  using	  any	  medications	  that	  may	  affect	  the	  response	  of	  the	  study	  variables.	  
• Breast	  cancer	  survivors	  did	  not	  alter	  their	  dietary	  practices	  during	  the	  study.	  	  Limitations	  
• This	  is	  a	  retrospective	  study	  and	  all	  data	  collection	  procedures	  could	  not	  be	  altered	  for	  this	  study.	  
• The	  results	  of	  this	  study	  may	  only	  apply	  to	  sedentary	  women	  between	  the	  ages	  of	  40-­‐70	  years,	  as	  well	  as	  breast	  cancer	  survivors	  for	  whom	  it	  has	  been	  3-­‐6	  months	  since	  receiving	  any	  major	  cancer	  treatment.	  The	  results	  of	  this	  study	  may	  not	  be	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able	  to	  be	  generalized	  to	  women	  of	  all	  ages,	  men,	  all	  cancer	  survivors,	  cancer	  patients	  currently	  undergoing	  major	  cancer	  treatment,	  or	  individuals	  who	  are	  exercise-­‐trained.	  	  
• Cancer	  survivors’	  exercise	  training	  prior	  to	  treatment	  could	  alter	  the	  inflammatory	  and	  immune	  response.	  
• Changes	  in	  cytokines	  were	  measured	  only	  in	  the	  blood.	  	  
• The	  different	  treatment	  regimens	  that	  breast	  cancer	  survivors	  underwent	  prior	  to	  the	  study	  could	  have	  influenced	  their	  exercise-­‐induced	  response.	  
• The	  intermittent	  nature	  of	  the	  exercise	  bout	  may	  differently	  influence	  the	  immune	  and	  inflammatory	  response	  compared	  to	  continuous	  exercise.	  	  Significance	  of	  study	  This	  study	  helped	  to	  clarify	  if	  inflammation	  is	  acutely	  altered	  after	  a	  bout	  of	  moderate	  intensity	  exercise	  in	  breast	  cancer	  survivors.	  	  Few	  studies	  have	  attempted	  to	  examine	  potential	  mediators	  of	  the	  exercise-­‐induced	  immune	  response	  in	  breast	  cancer	  patients,	  such	  as	  inflammatory	  markers.	  	  Most	  studies	  in	  this	  area	  have	  only	  looked	  at	  the	  inflammatory	  response	  to	  long-­‐term	  exercise	  training	  interventions	  in	  this	  population.	  	  However,	  it	  is	  important	  to	  understand	  the	  acute	  inflammatory	  response	  to	  exercise	  in	  order	  to	  monitor	  the	  safety	  and	  efficacy	  of	  implemented	  exercise	  programs	  for	  this	  population.	  	  Since	  inflammation	  is	  a	  mechanism	  of	  innate	  immunity,	  the	  immune	  system	  can	  potentially	  be	  helped	  if	  an	  acute	  bout	  of	  moderate	  intensity	  exercise	  can	  positively	  alter	  inflammatory	  markers	  (Bruunsgaard,	  2005).	  	  Thus,	  exercise	  may	  help	  mitigate	  some	  of	  the	  chronic	  inflammation	  and	  immunosuppression	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REVIEW	  OF	  LITERATURE	  	   	   For	  the	  purpose	  of	  organization,	  Chapter	  II	  will	  be	  organized	  into	  the	  following	  sections:	  	  I.	  Breast	  cancer	  facts,	  treatment-­‐related	  side	  effects,	  and	  general	  exercise	  benefits;	  II.	  Inflammation	  and	  immunology	  overview;	  III.	  Effects	  of	  exercise	  on	  markers	  of	  inflammation	  in	  healthy	  populations;	  IV.	  Cancer	  and	  markers	  of	  inflammation;	  V.	  Effects	  of	  exercise	  on	  markers	  of	  inflammation	  in	  breast	  cancer	  survivors;	  VI.	  Summary.	  	  Measures	  from	  the	  following	  reviewed	  articles	  have	  been	  delimited	  in	  relation	  to	  the	  measurements	  pertinent	  to	  the	  current	  study.	  	  	  	  
Breast	  cancer	  facts,	  treatment-­‐related	  side	  effects,	  and	  general	  exercise	  benefits	  Breast	  cancer	  facts	   	  Breast	  cancer	  is	  defined	  as	  a	  malignant	  tumor	  starting	  in	  the	  cells	  of	  the	  breast	  that	  may	  metastasize	  to	  distant	  areas	  of	  the	  body	  or	  invade	  surrounding	  tissues.	  	  Except	  for	  skin	  cancers,	  breast	  cancer	  is	  the	  most	  common	  form	  of	  cancer	  in	  women	  in	  America,	  and	  approximately	  12%	  of	  American	  women	  will	  develop	  invasive	  breast	  cancer	  throughout	  their	  lifetime	  (ACS,	  2013).	  	  In	  2013,	  it	  is	  estimated	  that	  approximately	  232,340	  new	  cases	  will	  be	  diagnosed	  along	  with	  39,620	  deaths	  among	  women	  from	  breast	  cancer	  in	  the	  United	  States	  (ACS,	  2013;	  Siegel	  et	  al.,	  2013).	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   Breast	  cancer	  treatment	  primarily	  consists	  of	  surgery,	  chemotherapy,	  radiation	  therapy,	  and	  hormone	  therapy.	  	  The	  method	  of	  administration	  depends	  on	  the	  type	  and	  stage	  of	  the	  breast	  cancer,	  and	  many	  of	  these	  treatments	  are	  combined	  according	  to	  the	  needs	  of	  the	  patient	  (NCI,	  2013).	  	  Common	  surgical	  treatments	  are	  used	  to	  remove	  cancer	  from	  the	  breast	  and	  may	  include	  lumpectomy,	  partial	  mastectomy,	  or	  total	  mastectomy.	  	  Chemotherapy	  is	  a	  treatment	  that	  destroys	  cancer	  cells	  by	  killing	  them	  or	  stopping	  their	  division	  and	  is	  administered	  both	  orally	  and	  intravenously.	  	  Radiation	  is	  another	  breast	  cancer	  treatment	  that	  uses	  high-­‐energy	  x-­‐rays	  to	  destroy	  cancer	  cells	  or	  prevent	  them	  from	  growing	  larger.	  	  Hormone	  therapy	  treatment	  removes	  hormones	  by	  preventing	  their	  release	  from	  endocrine	  glands	  and	  blocking	  their	  action	  in	  order	  to	  help	  stop	  cancer	  growth	  (NCI,	  2013).	  	  Targeted	  therapies	  are	  being	  developed	  that	  are	  tumor	  specific.	  	  These	  types	  of	  therapies	  are	  growing	  in	  number	  and	  include	  trastuzumab	  also	  known	  as	  Herceptin,	  which	  is	  a	  monoclonal	  antibody	  given	  to	  breast	  cancer	  survivors	  who	  overexpress	  the	  protein	  called	  human	  epidermal	  growth	  factor	  receptor	  2	  (HER2/neu	  receptor)	  that	  is	  responsible	  for	  promoting	  the	  growth	  of	  cancer	  cells	  (ACSM’s	  Guide	  to	  Exercise	  and	  Cancer	  Survivorship,	  2012).	  	  	  	  Breast	  cancer	  treatment-­‐related	  side	  effects	  Breast	  cancer	  survival	  rates	  have	  improved	  due	  to	  earlier	  detection	  through	  increased	  awareness	  and	  screening,	  advancements	  in	  modern	  technology,	  increased	  self-­‐examination,	  and	  improvements	  in	  treatment	  (Battaglini	  et	  al.,	  2008).	  	  Although	  survival	  rates	  have	  increased	  in	  the	  last	  several	  years,	  many	  negative	  adverse	  side	  effects	  can	  result	  from	  breast	  cancer	  treatment.	  	  Treatment-­‐related	  side	  effects	  may	  be	  acute,	  lasting	  over	  a	  period	  of	  days	  or	  weeks,	  or	  they	  may	  be	  persistent,	  lasting	  years	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after	  the	  completion	  of	  treatment	  (ACSM’s	  Guide	  to	  Exercise	  and	  Cancer	  Survivorship,	  2012).	  	  Pain,	  infection,	  tenderness,	  bleeding,	  and	  temporary	  swelling	  are	  among	  the	  side	  effects	  of	  surgical	  treatment	  for	  breast	  cancer	  (ACS,	  2013).	  	  Chemotherapy	  side	  effects	  may	  include	  weight	  changes,	  nausea,	  hair	  loss,	  fatigue,	  vomiting,	  and	  an	  increased	  chance	  of	  infections	  (ACSM’s	  Guide	  to	  Exercise	  and	  Cancer	  Survivorship,	  2012).	  	  Radiation	  treatments	  may	  cause	  patients	  to	  encounter	  soreness,	  fatigue,	  skin	  changes,	  and	  swelling	  (ACSM’s	  Guide	  to	  Exercise	  and	  Cancer	  Survivorship,	  2012).	  	  Side	  effects	  of	  hormone	  therapy	  may	  involve	  hot	  flashes,	  fatigue,	  vaginal	  discomfort,	  and	  mood	  swings	  (ACSM’s	  Guide	  to	  Exercise	  and	  Cancer	  Survivorship,	  2012).	  	  	  Overall,	  usual	  side	  effects	  observed	  in	  cancer	  patients	  that	  have	  undergone	  treatment	  are	  depression,	  worry,	  pain,	  cachexia,	  dyspnea,	  nausea,	  and	  fatigue	  (Battaglini	  et	  al.,	  2006).	  	  Studies	  have	  reported	  that	  70	  percent	  of	  patients	  undergoing	  chemotherapy	  and	  radiation	  have	  fatigue	  (Battaglini	  et	  al.,	  2007).	  	  Both	  radiation	  and	  chemotherapy	  have	  also	  been	  shown	  to	  cause	  necrotic	  death	  of	  cancer	  cells	  and	  surrounding	  tissues,	  which	  can	  result	  in	  increased	  inflammation	  in	  breast	  cancer	  patients	  (Grivennikov	  et	  al.,	  2010).	  	  In	  addition,	  cancer	  patients	  may	  experience	  depressed	  immune	  system	  parameters.	  	  Patients	  receiving	  chemotherapy	  have	  been	  shown	  to	  have	  suppressed	  NK	  cell	  counts	  compared	  to	  healthy	  populations	  (Shore	  et	  al.,	  1999).	  Exercise	  benefits	  on	  treatment-­‐related	  side	  effects	  There	  is	  now	  strong	  evidence	  found	  in	  epidemiologic	  studies	  that	  exercise	  may	  affect	  breast	  cancer	  risk	  reduction.	  	  In	  a	  systematic	  review	  conducted	  by	  C.	  M.	  Friedenreich,	  73	  epidemiologic	  studies	  were	  reviewed	  that	  provide	  evidence	  that	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physical	  activity	  reduces	  breast	  cancer	  risk	  by	  about	  25%	  (Friedenreich,	  2010).	  	  Exercise	  may	  also	  improve	  overall	  general	  health,	  and	  studies	  have	  shown	  that	  exercise	  can	  be	  a	  helpful	  tool	  in	  attenuating	  the	  physiological	  effects	  associated	  with	  breast	  cancer	  treatment.	  	  Improvements	  in	  cardiorespiratory	  fitness,	  body	  composition,	  physical	  functioning,	  quality	  of	  life,	  and	  fatigue	  have	  been	  shown	  by	  systematic	  review	  evidence	  in	  cancer	  survivors	  who	  exercise	  (DeBacker	  et	  al.,	  2008).	  	  	  Patients	  receiving	  cancer	  treatments	  in	  previous	  years	  were	  advised	  to	  rest	  and	  avoid	  activity	  known	  to	  further	  decrease	  energy	  levels.	  	  Exercise	  has	  been	  shown	  by	  scientific	  research	  to	  help	  alleviate	  the	  routine	  symptoms	  of	  cancer	  treatments	  such	  as	  pain,	  nausea,	  and	  fatigue.	  	  Possible	  benefits	  of	  exercise	  used	  to	  alter	  normal	  cancer	  treatment	  side	  effects	  include	  improved	  cardiovascular	  efficiency,	  increased	  mobilization,	  muscle	  regeneration,	  energy	  production	  enhancement,	  and	  stimulation	  of	  erythrocyte,	  leukocyte,	  and	  thrombocyte	  cell	  production	  (Battaglini	  et	  al.,	  2006).	  	  Numerous	  studies	  have	  generally	  demonstrated	  that	  exercise	  does	  indeed	  reduce	  insulin	  resistance,	  endogenous	  estrogen	  levels,	  adiposity	  levels,	  and	  inflammation	  (Friedenreich,	  2010).	  	  
Inflammation	  and	  immunology	  overview	  Inflammation	  
	   	   Inflammation	  can	  be	  described	  as	  a	  complex	  reaction	  of	  the	  innate	  immune	  system	  in	  tissues	  involving	  the	  accumulation	  and	  activation	  of	  plasma	  proteins	  and	  leukocytes	  at	  a	  site	  of	  cell	  injury,	  toxin	  exposure,	  or	  infection	  (Abbas,	  2005).	  	  Inflammation	  involves	  a	  progression	  of	  synchronized	  immune	  responses	  to	  tissue	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damage	  caused	  by	  physical	  agents	  such	  as	  trauma,	  surgery,	  or	  radiation.	  	  Other	  causes	  of	  inflammation	  may	  be	  due	  to	  infections	  by	  pathogens,	  either	  viral	  or	  bacterial	  (Zhou	  et	  al.,	  2010).	  	  The	  inflammatory	  process	  is	  considered	  to	  be	  homeostatic.	  	  In	  this	  process	  the	  host	  begins	  a	  complex	  series	  of	  humoral	  and	  cellular	  responses	  in	  an	  effort	  to	  limit	  tissue	  damage,	  isolate	  and	  destroy	  the	  invading	  organism,	  and	  activate	  the	  course	  of	  repair	  (Smith,	  2003).	  	  Inflammation	  can	  serve	  as	  a	  protective	  mechanism	  in	  promoting	  tissue	  repair	  and	  controlling	  infections,	  but	  it	  can	  also	  cause	  tissue	  damage	  and	  disease	  (Abbas,	  2005).	  	  	  Cytokines	  	   	   Cytokines	  are	  proteins	  produced	  by	  many	  different	  types	  of	  cells	  in	  response	  to	  microbes	  and	  other	  antigens	  that	  mediate	  inflammatory	  and	  immune	  reactions	  (Abbas,	  2005).	  	  The	  production	  of	  cytokines	  can	  be	  from	  macrophages	  and	  lymphocytes	  as	  well	  as	  other	  cells	  such	  as	  fibroblasts	  and	  endothelial	  cells	  (Smith,	  2003).	  	  Production	  of	  these	  proteins	  is	  increased	  in	  response	  to	  various	  stressors	  including	  injury,	  infection	  by	  microorganisms,	  normal	  growth	  demands,	  psychological	  distress,	  and	  inflammation	  (Corwin,	  2000).	  	  At	  low	  concentrations,	  many	  cytokines	  have	  beneficial	  effects,	  whereas	  tissue	  damage	  and	  multiple	  organ	  failure	  are	  associated	  with	  higher	  concentrations	  (Smith,	  2003).	  	  Cytokines	  are	  often	  involved	  in	  inflammation	  through	  their	  effects	  on	  cell	  recruitment,	  bone	  marrow	  differentiation,	  antigen	  presentation,	  cell	  activation,	  and	  cell	  adhesion	  molecule	  expression	  (Zhou	  et	  al.,	  2010).	  	  There	  are	  three	  broad	  classes	  of	  cytokines	  including	  lymphokines	  and	  monokines,	  growth	  factors,	  and	  colony-­‐stimulating	  factors	  (Corwin,	  2000).	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   Depending	  on	  the	  microenvironment,	  cytokines	  can	  be	  functionally	  separated	  into	  two	  categories:	  those	  that	  are	  inherently	  pro-­‐inflammatory	  and	  anti-­‐inflammatory.	  	  Pro-­‐inflammatory	  cytokines	  are	  important	  in	  the	  inception	  and	  advancement	  of	  inflammation.	  	  On	  the	  other	  hand,	  anti-­‐inflammatory	  cytokines	  inhibit	  certain	  conditions	  of	  adaptive	  immunity	  (Abbas,	  2005).	  	  Pro-­‐inflammatory	  cytokines	  are	  especially	  of	  interest	  to	  clinicians	  since	  they	  guide	  the	  immune	  response	  by	  the	  stimulation	  of	  white	  blood	  cell	  proliferation	  and	  cytotoxicity.	  	  These	  cytokines	  can	  be	  controlled	  by	  anti-­‐inflammatory	  cytokines	  through	  negative	  feedback	  (Corwin,	  2000).	  	  	  	   	   Cytokines	  are	  regarded	  as	  communication	  molecules	  that	  can	  act	  at	  any	  range	  (autocrine,	  paracrine,	  endocrine),	  and	  are	  important	  in	  activating	  local	  inflammatory/immune	  cells	  and	  regulating	  invasion	  of	  white	  blood	  cells	  into	  traumatized	  tissue	  (Smith,	  2003).	  	  Similar	  to	  classic	  hormones,	  cytokines	  act	  by	  binding	  to	  a	  receptor	  on	  a	  target	  cell	  to	  alter	  the	  function	  of	  the	  target	  cell	  (Corwin,	  2000).	  	  They	  act	  as	  immune	  regulators	  through	  interactions	  with	  specific	  membrane	  receptors	  (Zhou	  et	  al.,	  2010).	  	  Cytokines	  elicit	  cellular	  responses	  by	  activating	  signal	  transduction	  pathways	  within	  the	  cell.	  	  This	  is	  accomplished	  with	  the	  binding	  of	  cytokines	  to	  transmembrane	  cell	  surface	  receptors	  and	  ultimately	  leads	  to	  the	  introduction	  of	  new	  gene	  transcription	  and	  the	  synthesis	  of	  new	  cellular	  proteins	  (Chaplin,	  2010).	  	  	  	   	   The	  actions	  of	  cytokines	  are	  often	  pleiotropic,	  meaning	  one	  cytokine	  has	  the	  ability	  to	  act	  and	  induce	  a	  variety	  of	  responses	  on	  different	  cell	  types.	  	  This	  pleiotropic	  nature	  allows	  cytokines	  to	  mediate	  diverse	  biological	  effects	  whether	  it	  be	  regulating	  innate	  immunity,	  adaptive	  immunity,	  or	  stimulating	  hematopoiesis	  (Abbas,	  2005).	  	  Cytokines	  also	  exert	  redundant	  effects	  with	  multiple	  cytokines	  having	  the	  same	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functional	  effects	  (Abbas,	  2005).	  	  Virtually	  every	  system	  in	  the	  body	  is	  affected	  by	  cytokines.	  	  They	  also	  have	  an	  effect	  on	  all	  aspects	  of	  growth	  and	  development	  as	  well	  as	  every	  host	  response	  to	  injury,	  infection,	  and	  inflammation	  (Corwin,	  2000).	  	  Specific	  markers	  of	  inflammation	  	   	   Tumor	  necrosis	  factor	  (TNF-­‐α)	  is	  released	  from	  activated	  macrophages	  in	  response	  to	  increased	  concentrations	  of	  IL-­‐1	  and	  IL-­‐2	  and	  bacterial	  endotoxin	  (Corwin,	  2000).	  	  This	  pro-­‐inflammatory	  cytokine	  is	  responsible	  for	  many	  of	  the	  systemic	  complications	  of	  severe	  infections.	  	  TNF-­‐α	  is	  also	  an	  important	  mediator	  of	  the	  acute	  inflammatory	  response	  to	  infectious	  microbes	  (Abbas,	  2005).	  	  This	  cytokine	  acts	  to	  induce	  expression	  of	  IL-­‐1	  and	  IL-­‐2	  and	  stimulates	  the	  production	  of	  IL-­‐6,	  leading	  to	  increased	  signs	  of	  infection	  and	  inflammation	  as	  well	  as	  the	  production	  of	  acute	  phase	  proteins	  (Corwin,	  2000).	  	  One	  of	  the	  main	  physiological	  functions	  of	  TNF-­‐α	  is	  to	  stimulate	  the	  recruitment	  of	  monocytes	  and	  neutrophils	  to	  infection	  sites	  and	  activate	  these	  cells	  to	  eliminate	  microbes	  (Abbas,	  2005).	  	   	   C-­‐reactive	  protein	  (CRP)	  is	  an	  acute	  phase	  protein	  produced	  in	  the	  liver	  that	  has	  pro-­‐inflammatory	  characteristics	  and	  is	  a	  highly	  significant	  marker	  of	  inflammatory	  disease.	  	  CRP	  is	  an	  acute	  phase	  reactant	  due	  to	  the	  increase	  in	  its	  plasma	  levels	  during	  the	  acute	  stages	  of	  many	  infections	  (Abbas,	  2005).	  	  CRP	  is	  involved	  in	  the	  innate	  immune	  response	  to	  bacterial	  infections	  and	  is	  considered	  to	  be	  a	  member	  of	  the	  pentraxin	  family	  of	  plasma	  proteins.	  	  This	  protein	  is	  known	  to	  bind	  to	  the	  capsule	  of	  pneumococcal	  bacteria	  (Abbas,	  2005).	  	  Sedimentation	  rate	  is	  a	  blood	  test	  that	  can	  identify	  the	  presence	  of	  inflammation	  by	  measuring	  how	  quickly	  red	  blood	  cells	  settle	  in	  a	  test	  tube	  in	  one	  hour.	  	  The	  elevation	  in	  CRP	  as	  well	  as	  other	  acute	  phase	  proteins	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contributes	  to	  sedimentation	  rate	  increases	  that	  frequently	  accompany	  infective	  and	  inflammatory	  disease.	  	  In	  some	  circumstances	  the	  measurement	  of	  CRP	  may	  be	  considered	  to	  be	  a	  key	  indicator	  of	  morbidity	  relating	  to	  infective	  and	  inflammatory	  diseases	  in	  general	  (Corwin,	  2000).	  	   	   Interleukin-­‐10	  (IL-­‐10)	  is	  involved	  in	  controlling	  innate	  immunity	  reactions	  and	  cell-­‐mediated	  immunity	  through	  the	  suppression	  of	  activated	  macrophages	  and	  dendritic	  cells.	  	  IL-­‐10	  is	  produced	  by	  T	  cells	  and	  is	  an	  inhibitor	  of	  host	  immune	  responses,	  especially	  those	  involving	  macrophages	  (Abbas,	  2005;	  Corwin,	  2000).	  	  On	  the	  basis	  of	  cell-­‐mediated	  immunity	  and	  macrophage	  function,	  IL-­‐10	  is	  considered	  the	  most	  profound	  immunosuppressive	  cytokine	  (Smith,	  2003).	  	  IL-­‐10	  has	  an	  anti-­‐inflammatory	  property	  known	  to	  down-­‐regulate	  inflammatory	  cytokine	  production	  including	  TNF-­‐α,	  IL-­‐1,	  and	  IL-­‐6	  (Zhou	  et	  al.,	  2010).	  	  IL-­‐10	  may	  suppress	  cytokine	  synthesis	  by	  inhibiting	  the	  transcription	  of	  the	  genes	  of	  cells	  and	  by	  post-­‐transcriptional	  mechanisms	  (Petersen	  and	  Pedersen,	  2005).	  Cytokines	  and	  immunity	  	   	   Cytokines	  are	  considered	  the	  principal	  mediators	  of	  communication	  between	  cells	  of	  the	  immune	  system,	  functioning	  as	  key	  contributors	  to	  immunity	  and	  inflammation	  (Abbas,	  2005).	  	  These	  soluble	  proteins	  allow	  communication	  between	  immune	  cells	  with	  coordination	  of	  inflammatory	  responses	  (Zhou	  et	  al.,	  2010).	  	  Since	  cytokines	  are	  released	  from	  immune	  cells	  in	  a	  signaling	  fashion,	  they	  have	  strong	  roles	  in	  the	  up-­‐regulation	  of	  particular	  immune	  parameters	  (Pedersen,	  2000).	  	  The	  immune	  system	  employs	  many	  mechanisms	  working	  together	  to	  combat	  infection	  by	  microbes.	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This	  fully	  integrated	  immune	  response	  draws	  elements	  from	  multiple	  effector	  systems	  in	  order	  to	  modify	  a	  specific	  response	  to	  the	  invading	  pathogen	  (Chaplin,	  2010).	  	  	  Immune	  function	  	   	   The	  immune	  system	  is	  commonly	  divided	  into	  two	  main	  sectors	  including	  innate	  immunity	  and	  adaptive	  immunity.	  	  Both	  innate	  and	  adaptive	  mechanisms	  are	  used	  to	  detect	  and	  eliminate	  pathogenic	  microbes	  (Chaplin,	  2010).	  	  NK	  cells	  as	  well	  as	  monocytes/macrophages,	  T	  cytotoxic	  cells,	  and	  polymorphonuclear	  cells	  are	  involved	  in	  innate	  immunity.	  	  These	  cells	  help	  to	  form	  the	  “first	  line	  of	  defense,”	  and	  generally	  respond	  to	  any	  invading	  pathogen	  by	  rapidly	  recognizing	  common	  molecular	  patterns	  and	  indiscriminately	  attacking	  anything	  appearing	  to	  be	  foreign	  (Abbas,	  2005).	  	  The	  innate	  system	  is	  the	  initial	  host	  response	  due	  to	  the	  broad	  number	  of	  recognition	  molecules	  that	  act	  rapidly	  after	  an	  invading	  pathogen	  or	  toxin	  is	  encountered	  (Chaplin,	  2010;	  Seruga	  et	  al.,	  2008).	  	  NK	  cells	  are	  an	  important	  component	  of	  cell-­‐mediated	  immunity,	  and	  they	  are	  the	  most	  sensitive	  cells	  to	  typical	  stress-­‐induced	  immunosuppression	  (Smith,	  2003).	  	  NK	  cells	  are	  morphologically	  defined	  as	  large	  granular	  lymphocytes	  that	  recognize	  their	  targets	  using	  an	  elaborate	  accumulation	  of	  activating	  and	  inhibitory	  cell	  surface	  receptors	  (Chaplin,	  2010).	  	  These	  cells	  develop	  in	  bone	  marrow	  and	  have	  no	  antigen-­‐specific	  receptors.	  	  They	  can	  destroy	  target	  cells	  through	  antibody	  dependent	  cell-­‐mediated	  cytotoxicity.	  	  In	  addition,	  NK	  cells	  have	  prominent	  anti-­‐tumor	  effects	  and	  are	  potent	  killers	  of	  virally	  infected	  cells	  (Chaplin,	  2010).	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Effects	  of	  exercise	  on	  markers	  of	  inflammation	  in	  healthy	  populations	  Exercise	  and	  cytokine	  response	  	   	   Exercise	  modulates	  the	  immune	  system	  in	  healthy	  individuals	  and	  can	  work	  as	  a	  model	  of	  temporary	  immunosuppression	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000).	  	  The	  inflammatory	  regulation	  of	  exercise	  has	  been	  linked	  to	  the	  production	  of	  cytokines	  (Petersen	  and	  Pedersen,	  2005).	  	  Cytokines	  are	  released	  at	  the	  site	  of	  inflammation	  as	  a	  result	  of	  exercise,	  infection,	  or	  tissue	  injury.	  	  The	  exercise-­‐induced	  local	  inflammatory	  response	  is	  accompanied	  by	  a	  systemic	  response	  known	  as	  the	  acute	  phase	  response	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Ostrowski	  et	  al.,	  1999).	  	  This	  response	  includes	  the	  production	  of	  a	  large	  number	  of	  hepatocyte-­‐derived	  acute	  phase	  proteins,	  such	  as	  CRP	  (Petersen	  and	  Pedersen,	  2005).	  	  	  	   	   Although	  many	  different	  cell	  types	  produce	  plasma	  cytokines,	  muscle	  cells	  are	  a	  major	  source	  during	  exercise	  (Zhou	  et	  al.,	  2010).	  	  Muscle	  contractions	  can	  induce	  a	  myokine	  response,	  which	  is	  characterized	  by	  the	  release	  of	  cytokines,	  such	  as	  IL-­‐6,	  from	  working	  muscles.	  	  Regular	  muscle	  contraction	  can	  mediate	  signals	  with	  myokines	  that	  may	  suppress	  pro-­‐inflammatory	  activities	  at	  both	  distant	  sites	  as	  well	  as	  within	  the	  skeletal	  muscle	  itself	  (Bruunsgaard,	  2005).	  	   	   The	  cytokine	  response	  in	  relation	  to	  exercise	  may	  be	  initiated	  due	  to	  the	  mechanical	  disruption	  of	  myofibers.	  	  The	  production	  of	  cytokines	  resulting	  from	  exercise	  resembles	  that	  observed	  in	  relation	  to	  trauma	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000).	  	  However,	  many	  of	  the	  effects	  that	  come	  with	  the	  fully	  developed,	  systemic	  pro-­‐inflammatory	  response	  occurring	  with	  trauma	  do	  not	  happen	  with	  exercise.	  	  Although	  the	  initiation	  of	  the	  acute-­‐phase	  response	  develops,	  the	  lack	  of	  a	  fully	  developed	  
	   24	  
systemic	  response	  with	  exercise	  may	  be	  due	  to	  exercise	  only	  resulting	  in	  a	  transient	  release	  of	  cytokines	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000).	  	  Increases	  in	  pro-­‐inflammatory	  cytokines	  such	  as	  TNF-­‐α	  are	  minute	  due	  to	  exercise	  without	  muscle	  damage,	  and	  this	  indicates	  that	  in	  non-­‐traumatic	  exercise,	  the	  cytokine	  cascade	  differs	  importantly	  from	  the	  classical	  acute-­‐phase	  response	  in	  infectious	  systems	  (Bruunsgaard,	  2005).	  	  The	  fact	  that	  pro-­‐inflammatory	  cytokines	  such	  as	  TNF-­‐α	  may	  not	  increase	  with	  exercise	  provides	  evidence	  for	  the	  difference	  in	  the	  cytokine	  response	  to	  exercise	  compared	  to	  that	  of	  severe	  infections	  (Petersen	  and	  Pedersen,	  2005).	  	  Also,	  anti-­‐inflammatory	  cytokines,	  soluble	  receptors,	  and	  receptor	  antagonists	  can	  restrict	  the	  inflammatory	  response	  to	  exercise,	  potentially	  having	  an	  effect	  on	  exercise	  not	  producing	  a	  full	  systemic	  response	  (Ostrowski	  et	  al.,	  1999).	  	  	  	   	   	  Numerous	  studies	  have	  shown	  that	  several	  cytokines	  can	  be	  found	  in	  plasma	  both	  during	  and	  after	  exercise.	  	  While	  acute	  exercise	  protocols	  result	  in	  short	  term	  changes	  in	  particular	  cytokines,	  chronic	  exercise	  training	  may	  result	  in	  decreased	  levels	  of	  many	  circulating	  cytokines	  (Zhou	  et	  al.,	  2010).	  	  Exercise	  may	  also	  induce	  an	  increase	  in	  the	  systemic	  levels	  of	  a	  number	  of	  cytokines	  with	  anti-­‐inflammatory	  properties,	  and	  thereby	  can	  protect	  against	  chronic	  medical	  disorders	  associated	  with	  low-­‐grade	  systemic	  inflammation	  (Petersen	  and	  Pedersen,	  2005).	  	  Exercise	  in	  relation	  to	  the	  inflammatory	  process	  	   	   Epidemiological	  evidence	  supports	  the	  notion	  that	  a	  lifestyle	  with	  a	  high	  degree	  of	  physical	  activity	  is	  associated	  with	  attenuated	  circulating	  levels	  of	  TNF-­‐α,	  IL-­‐6,	  and	  CRP	  independently	  of	  age,	  gender,	  BMI,	  or	  blood	  glucose.	  	  Furthermore,	  a	  high	  level	  of	  physical	  activity	  is	  associated	  with	  reduced	  levels	  of	  peripheral	  inflammatory	  mediators	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in	  the	  range	  of	  20-­‐60%	  compared	  with	  a	  sedentary	  lifestyle	  (Bruunsgaard,	  2005).	  	  Even	  physical	  inactivity	  has	  been	  shown	  to	  be	  associated	  with	  low-­‐grade	  systemic	  inflammation	  in	  healthy	  subjects	  according	  to	  several	  cross-­‐sectional	  studies	  (Petersen	  and	  Pedersen,	  2005).	  	  In	  healthy	  individuals,	  elevated	  levels	  of	  CRP	  may	  be	  associated	  with	  increased	  body	  fat	  and	  sedentary	  lifestyles	  (Pierce	  et	  al.,	  2009b).	  	  Overall,	  multiple	  studies	  have	  found	  a	  strong	  inverse	  relationship	  between	  physical	  fitness	  and	  markers	  of	  inflammation	  (Markovitch	  et	  al.,	  2008).	  	  	   	   More	  frequent	  physical	  activity	  may	  help	  reduce	  the	  levels	  of	  systemic	  inflammation	  in	  the	  general	  population.	  	  Several	  cross-­‐sectional	  reports	  using	  general	  population	  samples	  have	  indicated	  that	  increased	  levels	  of	  exercise	  are	  associated	  with	  decreased	  levels	  of	  markers	  of	  inflammation	  such	  as	  C-­‐reactive	  protein	  (CRP)	  (Abramson	  and	  Vaccarino,	  2002).	  	  Abramson	  and	  Vaccarino	  (2002)	  found	  that	  a	  higher	  frequency	  of	  physical	  activity	  was	  independently	  associated	  with	  lower	  odds	  of	  having	  elevated	  inflammation	  levels,	  such	  as	  CRP	  and	  white	  blood	  cell	  count,	  among	  healthy	  middle-­‐aged	  and	  older	  US	  adults.	  	  This	  association	  was	  found	  even	  after	  adjustments	  were	  made	  for	  potential	  confounding	  factors	  including	  measures	  of	  general	  obesity	  (body	  mass	  index)	  and	  central	  obesity	  (waist-­‐to-­‐hip	  ratio),	  which	  have	  been	  shown	  to	  influence	  levels	  of	  inflammation	  (Abramson	  and	  Vaccarino,	  2002).	  	  Also,	  physical	  activity	  has	  been	  shown	  to	  be	  inversely	  associated	  with	  CRP	  concentrations	  in	  a	  representative	  sample	  of	  healthy	  adults	  in	  the	  US,	  suggesting	  that	  physical	  activity	  may	  mitigate	  inflammation	  (Ford,	  2002).	  	  	  	  	   	   Multiple	  studies	  indicate	  that	  the	  association	  between	  exercise	  and	  inflammation	  is	  not	  entirely	  mediated	  by	  reductions	  in	  obesity,	  and	  other	  mechanisms	  such	  as	  the	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antioxidant	  effects	  of	  exercise	  may	  be	  involved	  in	  the	  relationship	  between	  exercise	  and	  decreasing	  levels	  of	  inflammation	  (Abramson	  and	  Vaccarino,	  2002).	  	  It	  is	  possible	  that	  exercise	  training	  in	  general	  may	  reduce	  markers	  of	  inflammation,	  such	  as	  CRP,	  both	  directly	  and	  indirectly.	  	  Exercise	  may	  reduce	  CRP	  directly	  by	  reducing	  cytokine	  production	  in	  muscle,	  fat,	  and	  mononuclear	  cells	  and	  indirectly	  by	  reducing	  body	  weight,	  increasing	  insulin	  sensitivity,	  and	  improving	  endothelial	  function	  (Kasapis	  and	  Thompson,	  2005).	  	  Multiple	  studies	  have	  found	  an	  association	  between	  exercise	  and	  inflammation,	  but	  the	  mechanisms	  through	  which	  physical	  activity	  influences	  the	  inflammatory	  process	  are	  not	  all	  currently	  known	  (Ford,	  2002).	  	  	  	   	   Even	  light	  to	  moderate	  physical	  activity	  has	  been	  shown	  to	  be	  associated	  with	  lower	  blood	  concentrations	  of	  inflammatory	  markers,	  especially	  in	  cross-­‐sectional	  designs.	  	  Specifically,	  Pitsavos	  et	  al.	  (2003)	  found	  that	  leisure	  time	  physical	  activity	  was	  associated	  with	  33%	  lower	  concentrations	  of	  CRP	  and	  10%	  lower	  concentrations	  of	  white	  blood	  cell	  counts	  independent	  of	  age	  (Pitsavos	  et	  al.,	  2003).	  	  Also,	  only	  30	  minutes	  of	  moderate	  exercise	  on	  a	  regular	  basis	  may	  have	  the	  ability	  to	  facilitate	  an	  anti-­‐inflammatory	  environment	  represented	  by	  enhanced	  levels	  of	  cytokines	  such	  as	  IL-­‐10	  (Bruunsgaard,	  2005).	  	  Very	  few	  studies	  have	  examined	  the	  inflammatory	  response	  due	  to	  acute	  moderate-­‐intensity	  exercise,	  and	  the	  findings	  are	  controversial.	  	  While	  some	  studies	  have	  found	  increases	  in	  inflammatory	  markers	  due	  to	  acute	  moderate-­‐intensity	  exercise,	  others	  have	  found	  no	  changes	  in	  these	  markers	  (Nieman	  et	  al.,	  2005;	  Markovitch	  et	  al.,	  2008).	  	  It	  may	  be	  important	  to	  assess	  the	  inflammatory	  response	  to	  exercise	  by	  studying	  the	  long-­‐term	  versus	  acute	  effects	  of	  exercise,	  as	  well	  as	  the	  duration	  and	  intensity	  of	  the	  exercise	  (Markovitch	  et	  al.,	  2008).	  
	   27	  
Exercise-­‐induced	  anti-­‐inflammatory	  response	  	   	   Several	  studies	  have	  shown	  that	  physical	  activity	  mediates	  strong	  anti-­‐inflammatory	  effects	  in	  skeletal	  muscle	  and	  fat	  tissue.	  	  Exercise	  has	  the	  ability	  to	  produce	  acute	  increases	  in	  various	  anti-­‐inflammatory	  mediators	  (Kasapis	  and	  Thompson,	  2005).	  	  The	  anti-­‐inflammatory	  effects	  of	  exercise	  have	  been	  attributed	  to	  mechanisms	  that	  involve	  the	  cytokine	  IL-­‐6	  (Bruunsgaard,	  2005;	  Steensberg	  et	  al.,	  2003).	  	  IL-­‐6	  can	  increase	  as	  much	  as	  100-­‐fold	  after	  strenuous	  exercise,	  and	  this	  increase	  is	  the	  earliest	  as	  well	  as	  the	  most	  prominent	  cytokine	  response	  to	  exercise	  (Kasapis	  and	  Thompson,	  2005).	  	  There	  is	  controversy	  over	  whether	  IL-­‐6	  has	  pro-­‐	  or	  anti-­‐inflammatory	  properties,	  but	  some	  studies	  suggest	  IL-­‐6	  should	  be	  classified	  as	  an	  anti-­‐inflammatory	  cytokine	  due	  to	  the	  fact	  that	  IL-­‐6	  may	  stimulate	  the	  production	  of	  IL-­‐10	  and	  IL-­‐1ra	  while	  inhibiting	  the	  production	  of	  TNF-­‐α	  (Starkie	  et	  al.,	  2003;	  Steensberg	  et	  al.,	  2003).	  	  IL-­‐6	  has	  also	  been	  found	  to	  enhance	  the	  levels	  of	  both	  IL-­‐10	  and	  IL-­‐1ra,	  independently	  of	  TNF-­‐α	  (Steensberg	  et	  al.,	  2003).	  	  	   	   Starkie	  et	  al.	  (2003)	  found	  that	  physical	  activity	  may	  mediate	  anti-­‐inflammatory	  activity,	  and	  exercise-­‐induced	  IL-­‐6	  production	  may	  help	  to	  mediate	  the	  effect	  of	  exercise	  on	  TNF-­‐α	  production.	  	  Eight	  healthy	  subjects	  received	  an	  endotoxin	  bolus	  to	  induce	  low-­‐grade	  inflammation	  after	  2.5	  hours	  into	  a	  3-­‐hour	  bout	  of	  exercise	  on	  a	  cycle	  ergometer.	  	  Increases	  in	  TNF-­‐α	  from	  the	  endotoxin	  bolus	  were	  totally	  attenuated	  due	  to	  the	  exercise,	  whereas	  the	  endotoxin	  induced	  a	  two-­‐	  to	  threefold	  increase	  in	  circulating	  levels	  of	  TNF-­‐α	  during	  rest	  in	  the	  same	  subjects	  (Starkie	  et	  al.,	  2003).	  	  There	  are	  potentially	  other	  mediators,	  such	  as	  epinephrine,	  that	  may	  contribute	  to	  the	  anti-­‐inflammatory	  effects	  of	  exercise	  as	  well.	  	  Epinephrine	  is	  highly	  induced	  by	  exercise	  and	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has	  the	  ability	  to	  blunt	  the	  appearance	  of	  TNF-­‐α	  production	  (Starkie	  et	  al.,	  2003).	  	  The	  finding	  that	  exercise	  suppresses	  TNF-­‐α	  production	  has	  also	  been	  supported	  in	  animal	  models	  in	  which	  exercise	  normalized	  the	  overexpression	  of	  TNF-­‐α	  in	  TNF-­‐R	  knockout	  mice	  (Keller	  et	  al.,	  2004).	  	   	   In	  a	  2005	  review	  article	  by	  Petersen	  and	  Pedersen,	  circulating	  levels	  of	  anti-­‐inflammatory	  cytokines	  were	  commonly	  found	  in	  relation	  to	  exercise.	  	  As	  a	  result	  of	  exercise,	  increases	  primarily	  in	  IL-­‐6	  followed	  by	  increases	  in	  IL-­‐1ra	  and	  IL-­‐10	  have	  been	  thoroughly	  reported	  (Petersen	  and	  Pedersen,	  2005).	  	  The	  production	  of	  IL-­‐10	  that	  has	  been	  shown	  with	  exercise	  can	  lead	  to	  inhibition	  of	  the	  synthesis	  of	  a	  large	  range	  of	  pro-­‐inflammatory	  cytokines	  by	  different	  cells,	  notably	  of	  the	  monocytic	  line	  of	  descent.	  	  Therefore,	  IL-­‐10	  may	  be	  able	  to	  inhibit	  the	  production	  of	  TNF-­‐α	  by	  attenuating	  the	  surface	  expression	  of	  TNF-­‐α	  receptors	  (Petersen	  and	  Pedersen,	  2005;	  Steensberg	  et	  al.,	  2003).	  	  IL-­‐10	  may	  also	  be	  able	  to	  inhibit	  the	  production	  of	  IL-­‐1α	  and	  IL-­‐1β	  as	  well	  as	  the	  production	  of	  some	  chemokines.	  	  The	  anti-­‐inflammatory	  effects	  of	  an	  acute	  bout	  of	  exercise	  may	  protect	  against	  chronic	  systemic	  low-­‐grade	  inflammation,	  but	  a	  similar	  link	  between	  the	  acute	  effects	  of	  exercise	  and	  long-­‐term	  benefits	  has	  yet	  to	  be	  determined	  (Petersen	  and	  Pedersen,	  2005).	  	  	  	  	  Simultaneous	  increases	  in	  both	  pro-­‐	  and	  anti-­‐inflammatory	  markers	  due	  to	  exercise	  	   	   Exercise	  may	  induce	  an	  increase	  in	  pro-­‐inflammatory	  cytokines,	  such	  as	  TNF-­‐α.	  	  This	  release	  of	  pro-­‐inflammatory	  cytokines	  may	  also	  be	  balanced	  by	  the	  release	  of	  cytokine	  inhibitors	  and	  anti-­‐inflammatory	  cytokines,	  such	  as	  IL-­‐10.	  	  These	  findings	  suggest	  that	  anti-­‐inflammatory	  cytokines	  as	  well	  as	  cytokine	  inhibitors	  may	  restrict	  both	  the	  duration	  of	  the	  exercise	  and	  the	  exercise-­‐induced	  inflammatory	  response	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(Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Ostrowski	  et	  al.,	  1999).	  	  Therefore,	  there	  is	  a	  parallel	  anti-­‐inflammatory	  counter-­‐regulation	  that	  is	  also	  part	  of	  the	  acute	  phase	  response	  to	  exercise	  (Kasapis	  and	  Thompson,	  2005;	  Pedersen,	  2000).	  	   	   Ostrowski	  et	  al.	  (1999)	  found	  a	  significant	  increase	  in	  TNF-­‐α	  after	  a	  strenuous	  bout	  of	  exercise	  (marathon)	  in	  healthy	  adult	  males.	  	  Significant	  increases	  in	  the	  inflammation	  responsive	  cytokine	  IL-­‐6	  were	  also	  found	  following	  the	  exercise	  with	  only	  a	  modest	  increase	  in	  plasma	  CRP.	  	  Both	  anti-­‐inflammatory	  cytokines	  (IL-­‐10)	  and	  cytokine	  inhibitors	  were	  significantly	  increased	  due	  to	  the	  exercise,	  serving	  to	  balance	  the	  exercise-­‐induced	  release	  of	  pro-­‐inflammatory	  markers	  (Ostrowski	  et	  al.,	  1999).	  	  Contraction-­‐induced	  IL-­‐6	  expression	  may	  be	  followed	  by	  a	  systemic	  anti-­‐inflammatory	  response,	  providing	  a	  common	  underlying	  pathway	  by	  which	  pro-­‐inflammatory	  markers	  (TNF-­‐α	  activity)	  are	  attenuated	  after	  a	  single	  bout	  of	  exercise	  (Bruunsgaard,	  2005).	  	  Although	  strenuous	  exercise	  has	  been	  shown	  to	  result	  in	  positive	  changes	  in	  inflammatory	  markers,	  severe	  exercise	  or	  exercise	  in	  an	  immunosuppressed	  state	  may	  induce	  a	  negative	  inflammatory	  state	  as	  well	  as	  immunosuppression	  (Nieman	  et	  al.,	  1999;	  Smith,	  2000).	  	  This	  phenomenon	  called	  the	  “open	  window	  theory,”	  describes	  a	  period	  of	  time	  after	  exercise	  in	  which	  an	  individual	  may	  be	  subject	  to	  increased	  risk	  of	  infection	  due	  to	  a	  depression	  in	  immune	  function.	  	  “Over-­‐trained”	  states	  may	  result	  in	  the	  depression	  of	  key	  immune	  parameters,	  which	  have	  been	  linked	  to	  imbalances	  in	  cytokines	  (Nieman	  et	  al.,	  1999). 	  	   	   Even	  though	  strenuous	  exercise	  has	  been	  shown	  to	  induce	  an	  initial	  pro-­‐	  and	  anti-­‐inflammatory	  response,	  there	  may	  be	  a	  different	  effect	  as	  a	  result	  of	  moderate	  exercise	  in	  healthy	  individuals	  (Markovitch	  et	  al.,	  2008).	  	  Markovitch	  et	  al.	  (2008)	  found	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that	  acute	  moderate	  intensity	  exercise	  had	  no	  effect	  on	  pro-­‐	  or	  anti-­‐inflammatory	  responses.	  	  Twelve	  sedentary	  men	  underwent	  30	  minutes	  of	  walking	  at	  50%	  VO2max	  in	  which	  no	  significant	  changes	  were	  found	  in	  CRP,	  IL-­‐6,	  or	  IL-­‐10	  concentrations	  over	  the	  7	  days	  following	  the	  single	  bout	  of	  exercise.	  	  The	  results	  from	  this	  study	  may	  suggest	  that	  the	  long-­‐term	  anti-­‐inflammatory	  effects	  that	  were	  previously	  reported	  with	  exercise	  of	  moderate-­‐intensity	  must	  be	  explained	  by	  something	  other	  than	  a	  net	  anti-­‐inflammatory	  response	  to	  each	  exercise	  bout	  (Markovitch	  et	  al.,	  2008).	  	  	  Variability	  found	  in	  the	  levels	  of	  inflammatory	  markers	  across	  studies	  	   	   There	  have	  been	  many	  differences	  found	  between	  markers	  of	  inflammation	  due	  to	  exercise.	  	  Inconsistent	  findings	  have	  been	  reported	  for	  TNF-­‐α	  and	  CRP	  in	  response	  to	  exercise	  (Ostrowski	  et	  al.,	  1999).	  	  There	  are	  several	  possible	  explanations	  for	  these	  variable	  results	  on	  cytokines	  in	  relation	  to	  exercise	  including:	  1)	  the	  intensity	  and	  duration	  of	  the	  exercise	  as	  well	  as	  the	  type	  of	  physical	  activity;	  2)	  the	  specificity	  and	  the	  sensitivity	  of	  the	  assays	  used	  in	  particular	  studies;	  3)	  heterogeneity	  of	  subjects	  from	  sample	  to	  sample	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Pedersen,	  2000).	  	  Increased	  cytokine	  levels	  have	  mainly	  been	  described	  due	  to	  eccentric	  training,	  but	  concentric	  exercise	  can	  induce	  cytokine	  production	  as	  well.	  	  Also,	  the	  magnitude	  of	  the	  increases	  found	  in	  markers	  of	  inflammation	  is	  closely	  related	  to	  the	  duration	  of	  the	  exercise	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Pedersen,	  2000).	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Cancer	  and	  markers	  of	  inflammation	  Cancer	  and	  inflammation	  	   	   Increased	  circulating	  levels	  of	  cytokines	  are	  known	  to	  be	  associated	  with	  cancer,	  and	  epidemiological	  findings	  have	  shown	  a	  strong	  association	  between	  chronic	  inflammation	  and	  some	  types	  of	  cancer	  (Gomez	  et	  al.,	  2011;	  Seruga	  et	  al.,	  2008).	  	  Inflammatory	  cells	  may	  have	  powerful	  effects	  on	  tumor	  development,	  and	  inflammation	  has	  been	  shown	  to	  act	  as	  a	  tumor	  promoter.	  	  Inflammation	  can	  affect	  tumor	  development	  and	  progression	  in	  addition	  to	  the	  response	  to	  therapy	  (Balkwill	  and	  Mantovani,	  2001;	  Grivennikov	  et	  al.,	  2010).	  	  Cytokines	  are	  mediators	  that	  govern	  a	  vast	  range	  of	  processes	  involved	  in	  the	  development	  of	  cancer,	  and	  markers	  of	  inflammation	  form	  a	  major	  part	  of	  the	  tumor	  microenvironment	  (Candido	  and	  Hagemann,	  2013).	  	  Inflammatory	  cells	  as	  well	  as	  cytokines	  regulate	  the	  entire	  tumor	  organ,	  managing	  the	  migration,	  growth,	  and	  differentiation	  of	  all	  types	  of	  cells	  in	  the	  tumor	  microenvironment	  (Coussens	  and	  Werb,	  2002).	  	  These	  cytokines	  can	  also	  influence	  immunosuppression	  and	  tissue	  remodeling	  in	  the	  inflammatory	  microenvironment,	  which	  is	  a	  critical	  component	  of	  all	  tumors	  (Grivennikov	  et	  al.,	  2010;	  Seruga	  et	  al.,	  2008).	  	  	  	   	   An	  irregular	  balance	  between	  pro-­‐	  and	  anti-­‐inflammatory	  mechanisms	  often	  occurs	  in	  the	  cancer	  population,	  leading	  to	  chronic	  inflammation	  as	  well	  as	  chronic	  immune	  activation	  (Seruga	  et	  al.,	  2008).	  	  Cytokines	  such	  as	  TNF-­‐α	  may	  play	  a	  role	  in	  tumor	  progression	  by	  producing	  an	  optimal	  environment	  for	  tumor	  growth,	  promoting	  angiogenesis,	  and	  assisting	  genomic	  instability	  (Coussens	  and	  Werb,	  2002).	  	  Tumor	  growth	  initially	  depends	  on	  increased	  cell	  proliferation	  and	  reduced	  cell	  death,	  both	  of	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which	  are	  stimulated	  by	  inflammation-­‐driven	  mechanisms.	  	  Tumor	  promotion	  that	  is	  induced	  by	  inflammation	  may	  occur	  early	  or	  late	  in	  tumor	  development	  (Grivennikov	  et	  al.,	  2010).	  	  A	  common	  view	  about	  the	  cause	  of	  cancer	  is	  that	  inflammation	  may	  promote	  cancer,	  but	  recent	  evidence	  has	  shown	  that	  cancer	  may	  cause	  inflammation.	  	  Cancer-­‐induced	  inflammation	  may	  be	  due	  to	  the	  activation	  of	  intrinsic	  inflammation	  pathways	  by	  genetic	  events	  that	  cause	  neoplasia	  (Candido	  and	  Hagemann,	  2013).	  	   	   Recruitment	  of	  inflammatory	  markers	  may	  also	  interfere	  with	  tumor	  development	  and	  mediate	  the	  suppression	  of	  tumor	  growth.	  	  Although	  inflammatory	  responses	  may	  also	  be	  anti-­‐tumor,	  cancer	  patients	  often	  have	  abnormal	  inflammatory	  responses	  (Standish	  et	  al.,	  2008).	  	  These	  abnormal	  responses	  may	  arise	  from	  two	  different	  mechanisms:	  failure	  to	  up-­‐regulate	  anti-­‐inflammatory	  cytokines	  or	  disruption	  of	  the	  host	  response	  from	  the	  desensitization	  of	  receptors.	  	  The	  latter	  of	  the	  two	  mechanisms	  may	  lead	  to	  increased	  cytokine	  concentrations,	  attenuating	  systemic	  responses	  (Coussens	  and	  Werb,	  2002).	  	  The	  development	  of	  malignancy	  in	  some	  cancers	  may	  be	  preceded	  by	  inflammatory	  conditions,	  while	  other	  cancers	  may	  have	  oncogenic	  changes	  driving	  a	  tumor-­‐promoting	  inflammatory	  environment.	  	  Regardless	  of	  the	  origin,	  this	  inflammation	  may	  aid	  in	  the	  growth	  and	  survival	  of	  malignant	  cells,	  angiogenesis,	  and	  metastasis.	  	  In	  addition,	  responses	  to	  hormones	  and	  chemotherapy	  drugs	  may	  be	  potentially	  altered	  (Candido	  and	  Hagemann,	  2013).	  Pre-­‐treatment	  markers	  of	  inflammation	  in	  breast	  cancer	  patients	  	   	   Before	  surgery,	  breast	  cancer	  patients	  have	  been	  shown	  to	  exhibit	  elevated	  levels	  of	  CRP,	  with	  higher	  stages	  of	  breast	  cancer	  resulting	  in	  even	  larger	  concentrations	  of	  CRP.	  	  This	  may	  insinuate	  that	  CRP	  is	  related	  to	  tumor	  progression	  in	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these	  patients	  (Pierce	  et	  al.,	  2009a).	  	  Also,	  high	  levels	  of	  the	  cytokine	  IL-­‐6	  has	  been	  shown	  to	  potentially	  be	  a	  predisposing	  genetic	  factor	  contributing	  to	  worse	  breast	  cancer	  prognosis	  (Germano	  et	  al.,	  2008;	  Hutnick	  et	  al.,	  2005).	  	  It	  has	  been	  found	  that	  cancer	  survivors	  with	  chronic	  inflammation	  may	  have	  an	  overall	  higher	  risk	  of	  recurrence	  due	  to	  the	  effects	  of	  the	  inflammatory	  processes	  on	  cell	  growth	  (Pierce	  et	  al.,	  2009a).	  	   	   Altered	  inflammatory	  responses	  occur	  frequently	  in	  women	  with	  breast	  cancer,	  and	  studies	  have	  related	  breast	  cancer	  to	  an	  inflammation	  etiology	  (Standish	  et	  al.,	  2008).	  	  It	  has	  been	  reported	  that	  CRP,	  TNF-­‐α,	  and	  IL-­‐6	  are	  elevated	  in	  breast	  cancer	  patients	  (Seruga	  et	  al.,	  2008).	  	  As	  previously	  mentioned,	  IL-­‐6	  has	  been	  found	  to	  correlate	  with	  both	  cancer	  stage	  and	  degree	  of	  metastasis	  as	  well	  as	  breast	  cancer	  recurrence	  (Hutnick	  et	  al.,	  2005).	  	  Also,	  increased	  CRP	  levels	  may	  be	  associated	  with	  mortality	  in	  women	  diagnosed	  with	  breast	  caner	  (Jones	  et	  al.,	  2012).	  	  	   	  Breast	  cancer	  treatments	  and	  inflammation	  	   	   Surgery,	  chemotherapy,	  and	  radiation	  can	  all	  induce	  local	  or	  systemic	  increases	  in	  inflammation	  (Jones	  et	  al.,	  2009).	  	  Surgery	  may	  result	  in	  tissue	  injury	  through	  the	  activation	  of	  stress-­‐sensing	  pathways.	  	  Chemotherapy	  and	  radiation	  may	  result	  in	  cancer	  cell	  death	  through	  necrosis,	  which	  is	  a	  pro-­‐inflammatory	  form	  of	  cell	  death	  (Grivennikov	  et	  al.,	  2010).	  	  Different	  cancer	  treatments	  can	  activate	  the	  immune	  system	  to	  generate	  pro-­‐inflammatory	  cytokines	  that	  have	  been	  associated	  with	  toxic	  effects	  of	  treatment,	  such	  as	  bone	  loss,	  flu-­‐like	  effects,	  and	  fatigue.	  	  Increases	  in	  this	  category	  of	  cytokines	  have	  also	  been	  related	  to	  cachexia,	  pain,	  and	  resistance	  to	  treatment	  in	  cancer	  patients	  (Seruga	  et	  al.,	  2008).	  	  Cancer	  and	  some	  of	  its	  treatments	  can	  encourage	  an	  up-­‐
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regulation	  of	  pro-­‐inflammatory	  cytokines	  in	  which	  many	  of	  these	  cytokines	  may	  promote	  a	  metabolic	  state	  or	  other	  condition	  that	  results	  in	  tissue	  losses	  (Battaglini	  et	  al.,	  2012).	  	  There	  is	  also	  growing	  evidence	  that	  links	  inflammation	  and	  fatigue	  both	  during	  and	  after	  cancer	  treatment.	  	  Chemotherapy	  has	  been	  associated	  with	  acute	  increases	  in	  markers	  of	  inflammation	  as	  well	  as	  fatigue,	  which	  may	  last	  long	  into	  survivorship	  (Bower	  et	  al.,	  2011).	  	  	  	   	   On	  the	  other	  hand,	  chemotherapy	  and	  radiation	  may	  be	  used	  to	  eliminate	  the	  tumor-­‐promoting	  inflammatory	  microenvironment	  by	  causing	  the	  death	  of	  tumor-­‐promoting	  immune/inflammatory	  cells	  (Grivennikov	  et	  al.,	  2010).	  	  Activation	  of	  the	  immune	  system	  by	  cancer	  treatments	  might	  also	  have	  a	  role	  in	  producing	  anti-­‐cancer	  effects	  by	  differentially	  altering	  the	  secretion	  of	  cytokines	  (Seruga	  et	  al.,	  2008).	  	  Although	  cancer	  treatments	  attempt	  to	  reduce	  markers	  of	  inflammation,	  the	  majority	  of	  breast	  cancer	  survivors	  have	  been	  shown	  to	  display	  increased	  levels	  of	  inflammation	  compared	  to	  healthy	  women	  (Seruga	  et	  al.,	  2008).	  Breast	  cancer	  survivors	  and	  higher	  levels	  of	  inflammation	  	   	   Survivors	  of	  breast	  cancer	  have	  been	  shown	  to	  have	  higher	  levels	  of	  circulating	  cytokines	  and	  receptors	  than	  their	  healthy	  counterparts	  (Gomez	  et	  al.,	  2011;	  Seruga	  et	  al.,	  2008).	  	  Systemic	  inflammation	  has	  been	  shown	  to	  potentially	  be	  an	  important	  long-­‐term	  prognostic	  factor	  for	  breast	  cancer.	  	  A	  significant	  association	  has	  been	  found	  between	  reduced	  overall	  survival	  and	  increased	  concentrations	  of	  inflammatory	  markers,	  such	  as	  CRP	  (Pierce	  et	  al.,	  2009a).	  	  According	  to	  Seruga	  et	  al.	  (2008),	  preliminary	  data	  indicates	  that	  circulating	  levels	  of	  different	  pro-­‐	  and	  anti-­‐inflammatory	  cytokines	  are	  significantly	  higher	  in	  breast	  cancer	  survivors	  up	  to	  5	  years	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after	  diagnosis	  than	  in	  healthy	  controls	  (Seruga	  et	  al.,	  2008).	  	  Measurement	  of	  percent	  body	  fat	  has	  been	  found	  to	  be	  the	  most	  important	  predictor	  of	  inflammatory	  markers	  in	  breast	  cancer	  survivors.	  	  Increased	  body	  fat	  may	  be	  associated	  with	  increases	  in	  inflammation,	  and	  considering	  that	  many	  breast	  cancer	  survivors	  are	  overweight	  or	  obese,	  increased	  body	  fat	  could	  cause	  additional	  problems	  in	  the	  inflammatory	  microenvironment	  of	  these	  patients	  (Pierce	  et	  al.,	  2009b).	  	  It	  has	  been	  reported	  that	  more	  than	  50%	  of	  breast	  cancer	  survivors	  are	  overweight	  or	  obese,	  and	  the	  breast	  cancer	  survivors	  who	  gain	  weight	  may	  have	  increased	  levels	  of	  inflammation	  (Jones	  et	  al.,	  2012).	  	  With	  weight	  gain,	  fat	  cells	  in	  the	  breast	  expand	  and	  are	  more	  likely	  to	  die.	  	  The	  death	  of	  these	  cells	  may	  trigger	  the	  release	  of	  saturated	  fatty	  acids,	  which	  activate	  macrophages.	  	  Fatty	  acids	  that	  bind	  to	  the	  receptors	  of	  macrophages	  may	  start	  the	  cascade	  of	  inflammation	  by	  triggering	  the	  production	  of	  IL-­‐1,	  IL-­‐6,	  and	  TNF-­‐α	  (Patlak	  and	  Nass,	  2012).	  	   	   Breast	  cancer	  survivors	  with	  higher	  stages	  of	  breast	  cancer	  and	  metastases	  may	  have	  higher	  levels	  of	  pro-­‐inflammatory	  cytokines	  than	  those	  with	  lower	  stages	  and	  non-­‐metastatic	  cancer	  (Gomez	  et	  al.,	  2011).	  	  Higher	  levels	  of	  pro-­‐inflammatory	  cytokines	  may	  be	  a	  primary	  cause	  of	  fatigue	  in	  these	  patients,	  since	  persistent	  fatigue	  has	  been	  associated	  with	  increased	  levels	  of	  these	  inflammatory	  markers	  in	  breast	  cancer	  survivors	  (Seruga	  et	  al.,	  2008).	  	  Chemotherapy	  has	  been	  associated	  with	  increases	  in	  inflammation	  and	  fatigue,	  and	  findings	  have	  suggested	  that	  TNF-­‐α	  may	  play	  a	  significant	  role	  in	  chemotherapy-­‐induced	  fatigue.	  	  Also,	  animal	  models	  have	  shown	  chemotherapy-­‐induced	  rises	  in	  TNF-­‐α	  have	  led	  to	  increased	  oxidative	  stress	  and	  inflammation	  in	  the	  brain	  (Bower	  et	  al.,	  2011).	  	  Considering	  fatigue	  is	  one	  of	  the	  most	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common	  side	  effects	  experienced	  among	  breast	  cancer	  survivors,	  the	  reduction	  of	  pro-­‐inflammatory	  cytokines	  may	  be	  essential	  in	  improving	  the	  quality	  of	  life	  in	  breast	  cancer	  survivors	  (Seruga	  et	  al.,	  2008)	  	  Potential	  reasons	  for	  elevated	  inflammation	  in	  breast	  cancer	  survivors	  	   	   It	  has	  been	  noted	  that	  future	  cancer	  therapies	  should	  focus	  on	  normalizing	  the	  inflammatory	  network	  in	  order	  to	  re-­‐establish	  an	  overall	  normal	  host	  response	  (Coussens	  and	  Werb,	  2002).	  	  The	  occurrence	  of	  therapy-­‐induced	  inflammation	  is	  possible,	  and	  the	  various	  forms	  of	  therapy	  that	  can	  induce	  the	  death	  of	  malignant	  cells	  may	  activate	  cytokine-­‐producing	  inflammatory	  cells	  (Grivennikov	  et	  al.,	  2010).	  	  Current	  cancer	  treatments	  may	  not	  be	  able	  to	  completely	  diminish	  the	  high	  levels	  of	  tumor-­‐promoting	  mediators,	  such	  as	  pro-­‐inflammatory	  cytokines	  while	  increasing	  tumor-­‐suppressing	  factors,	  such	  as	  anti-­‐inflammatory	  cytokines	  (Candido	  and	  Hagemann,	  2013).	  	  The	  destruction	  of	  tumor	  cells	  has	  been	  the	  concentration	  of	  cancer	  treatments	  for	  many	  years.	  	  Proposed	  strategies	  to	  moderate	  the	  host	  microenvironment	  offer	  supplemental	  approaches	  to	  cancer	  treatment,	  and	  cancer-­‐associated	  inflammation	  may	  be	  an	  interesting	  target	  of	  anti-­‐tumor	  therapies	  in	  the	  future	  (Germano	  et	  al.,	  2008;	  Mantovani	  et	  al.,	  2008).	  	  	  	  	  	  	  	   	   Inhibiting	  antibodies	  that	  have	  been	  shown	  to	  have	  a	  significant	  therapeutic	  effect	  in	  other	  inflammatory	  diseases	  may	  be	  applicable	  to	  cancer	  therapies	  (Coussens	  and	  Werb,	  2002).	  	  Even	  though	  cancer	  therapies	  attempt	  to	  reduce	  inflammation,	  this	  is	  not	  always	  successful	  and	  may	  be	  one	  of	  the	  reasons	  why	  many	  cancer	  survivors	  have	  elevated	  levels	  of	  inflammation.	  	  In	  some	  instances,	  inflammation	  has	  been	  shown	  to	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diminish	  the	  beneficial	  effects	  of	  cancer	  therapy	  (Balkwill	  and	  Mantovani,	  2001).	  	  Also,	  cancer	  therapy,	  such	  as	  chemotherapy	  and	  radiation,	  may	  cause	  a	  strong	  tumor-­‐associated	  inflammatory	  response	  due	  to	  the	  necrotic	  death	  of	  cancer	  cells	  and	  surrounding	  tissues	  that	  can	  occur	  with	  these	  types	  of	  treatments	  (Grivennikov	  et	  al.,	  2010).	  	  	   	   	  Discussions	  about	  the	  breast	  cancer	  population	  and	  inflammation	  in	  different	  studies	  allude	  to	  things,	  but	  mechanisms	  as	  to	  why	  breast	  cancer	  survivors	  have	  increased	  inflammation	  are	  speculative	  as	  of	  now.	  	  Although	  it	  is	  evident	  that	  inflammatory	  processes	  may	  have	  a	  role	  in	  the	  progression	  of	  tumors,	  not	  much	  is	  known	  why	  these	  survivors	  still	  have	  increased	  levels	  of	  inflammation	  after	  cancer	  treatment	  (Grivennikov	  et	  al.,	  2010).	  	  The	  following	  are	  possible	  mechanisms	  for	  why	  this	  is	  occurring:	  1)	  Treatment-­‐related	  increases	  in	  inflammation	  with	  muscle	  and	  tissue	  damage	  due	  to	  cancer	  treatments;	  2)	  Treatments	  potentially	  not	  being	  able	  to	  alleviate	  inflammatory	  markers	  that	  could	  have	  led	  to	  metastasis	  in	  the	  first	  place	  (Chaplin,	  2010;	  Mantovani	  et	  al.,	  2008).	  	  How	  far	  the	  cancer	  progression	  was	  in	  each	  patient	  before	  treatment	  could	  potentially	  be	  a	  big	  determinant	  in	  how	  well	  the	  treatment	  can	  decrease	  and	  return	  levels	  of	  inflammation	  to	  normal	  in	  the	  breast	  cancer	  population	  (Gomez	  et	  al.,	  2011).	  	  	  	  
Effects	  of	  exercise	  on	  markers	  of	  inflammation	  in	  breast	  cancer	  survivors Exercise	  and	  inflammation	  in	  breast	  cancer	  survivors	  	   	   It	  has	  been	  suggested	  by	  several	  studies	  that	  physical	  activity	  is	  associated	  with	  a	  modest	  decrease	  in	  mortality	  for	  breast	  cancer	  patients	  (Pierce	  et	  al.,	  2009).	  	  In	  
	   38	  
observational	  studies,	  better	  lifestyle	  choices	  including	  moderate	  intensity	  exercise	  have	  resulted	  in	  improved	  survival	  after	  treatment	  of	  patients	  with	  breast	  cancer	  (Janelsins	  et	  al.,	  2011;	  Seruga	  et	  al.,	  2008).	  	  It	  is	  evident	  that	  appropriate	  amounts	  of	  physical	  activity	  may	  promote	  an	  up-­‐regulation	  of	  anti-­‐inflammatory	  cytokines	  while	  down	  regulating	  the	  expression	  of	  some	  pro-­‐inflammatory	  cytokines	  (Battaglini	  et	  al.,	  2012).	  	  Preliminary	  findings	  support	  this	  shift	  in	  a	  healthier	  inflammatory	  cytokine	  profile	  with	  physical	  activity	  in	  cancer	  patients,	  which	  may	  result	  in	  an	  improved	  muscle	  tissue	  status	  as	  well	  as	  an	  acceleration	  of	  protein	  synthesis	  within	  the	  skeletal	  muscle	  (Battaglini	  et	  al.,	  2012).	  	  Several	  exercise	  trials	  with	  breast	  cancer	  survivors	  have	  found	  reductions	  in	  both	  pro-­‐inflammatory	  markers	  and	  adiposity,	  and	  it	  has	  been	  postulated	  that	  physical	  activity’s	  effects	  on	  cytokine	  levels	  may	  be	  mediated	  through	  fat	  loss	  (Jones	  et	  al.,	  2012).	  	  	  	   	   Exercise	  has	  been	  shown	  to	  reduce	  inflammatory	  markers,	  such	  as	  CRP,	  independent	  of	  changes	  in	  body	  fat	  due	  to	  the	  modification	  of	  cytokine	  production	  at	  non-­‐adipose	  sites	  such	  as	  mononuclear	  cells	  and	  skeletal	  muscle.	  	  Reductions	  in	  inflammatory	  markers	  with	  exercise	  may	  occur	  indirectly	  through	  improved	  endothelial	  function,	  reduced	  body	  weight,	  or	  increased	  insulin	  sensitivity	  (Pierce	  et	  al.,	  2009b).	  	  The	  potential	  anti-­‐inflammatory	  effect	  of	  physical	  activity	  could	  explain	  the	  better	  outcome	  of	  cancer	  found	  in	  observational	  studies.	  	  Cumulative	  anti-­‐inflammatory	  effects	  of	  repeated	  exercise	  bouts	  could	  be	  one	  of	  the	  mechanisms	  responsible	  for	  the	  health	  benefits	  of	  regular	  exercise	  (Gomez	  et	  al.,	  2011).	  	  A	  physically	  active	  lifestyle	  has	  been	  shown	  to	  decrease	  production	  of	  pro-­‐inflammatory	  cytokines	  in	  non-­‐cancer	  populations	  and	  has	  been	  reported	  to	  improve	  blood	  immune	  function	  in	  breast	  cancer	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survivors.	  	  Increasing	  evidence	  suggests	  that	  exercise	  may	  be	  an	  important	  part	  of	  the	  lifestyle	  of	  breast	  cancer	  survivors	  in	  improving	  treatment-­‐related	  fatigue	  as	  well	  as	  preventing	  cancer	  recurrence	  and	  death	  (Seruga	  et	  al.,	  2008).	  	  	  	  	   	   Regular	  exercise	  has	  been	  shown	  to	  reduce	  pro-­‐inflammatory	  cytokines	  in	  people	  with	  chronic	  conditions,	  such	  as	  cardiovascular	  disease,	  but	  the	  beneficial	  effects	  of	  exercise	  in	  cancer	  survivors	  remains	  to	  be	  determined	  (Gomez	  et	  al.,	  2011).	  	  To	  date,	  very	  few	  studies	  in	  post-­‐treatment	  breast	  cancer	  patients	  have	  examined	  the	  effects	  of	  exercise	  on	  inflammatory	  markers,	  especially	  the	  inflammatory	  response	  to	  an	  acute	  bout	  of	  exercise.	  	  Most	  studies	  have	  only	  reported	  the	  inflammatory	  response	  due	  to	  long-­‐term	  exercise	  interventions	  in	  this	  population.	  	  Also,	  the	  majority	  of	  these	  studies	  are	  generally	  small,	  and	  the	  evidence	  is	  not	  consistent	  (Löf	  et	  al.,	  2012).	  	  Specific	  studies	  examining	  exercise	  and	  inflammatory	  markers	  in	  breast	  cancer	  survivors	  	   	   	  	   	   Fairey	  et	  al.	  (2005)	  examined	  the	  effect	  of	  an	  exercise	  intervention	  on	  markers	  of	  inflammation	  in	  breast	  cancer	  survivors.	  	  Fifty-­‐three	  postmenopausal	  breast	  cancer	  survivors	  were	  randomized	  into	  either	  a	  control	  or	  exercise	  group	  in	  which	  the	  subjects	  in	  the	  exercise	  group	  trained	  on	  cycle	  ergometers	  three	  times	  per	  week	  for	  15	  weeks.	  	  The	  researchers	  found	  no	  significant	  changes	  between	  the	  groups	  in	  cytokine	  production	  by	  blood	  mononuclear	  cells.	  	  Although	  the	  study	  did	  not	  find	  changes	  in	  cytokine	  production,	  the	  authors	  did	  find	  significant	  improvement	  in	  blood	  immune	  function	  due	  to	  the	  exercise	  training	  with	  an	  increase	  in	  NK	  cell	  cytotoxic	  activity	  (Fairey	  et	  al.,	  2005a).	  	   	   Gomez	  et	  al.	  (2011)	  found	  no	  significant	  changes	  in	  TNF-­‐α,	  IL-­‐10,	  or	  IL-­‐6	  among	  other	  cytokines	  in	  breast	  cancer	  survivors	  after	  a	  combined	  aerobic	  and	  resistance	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exercise	  training	  program.	  	  The	  breast	  cancer	  survivors	  underwent	  three	  sessions	  per	  week	  for	  a	  total	  of	  8	  weeks.	  	  The	  training	  program	  was	  not	  able	  to	  decrease	  circulating	  levels	  of	  pro-­‐inflammatory	  cytokines	  or	  increase	  levels	  of	  major	  anti-­‐inflammatory	  cytokines.	  	  However,	  the	  authors	  did	  observe	  a	  decrease	  in	  the	  IL-­‐10/TNF-­‐α	  ratio	  in	  these	  subjects	  due	  to	  the	  exercise	  that	  approached	  significance.	  	  The	  authors	  noted	  that	  the	  decrease	  found	  in	  the	  IL-­‐10/TNF-­‐α	  ratio	  might	  indicate	  that	  the	  exercise	  intervention	  did	  have	  an	  anti-­‐inflammatory	  effect	  on	  the	  breast	  cancer	  survivors.	  	  The	  research	  team	  then	  went	  on	  to	  suggest	  that	  perhaps	  a	  more	  intense	  or	  longer	  exercise	  intervention	  may	  be	  necessary	  in	  order	  to	  induce	  a	  significant	  anti-­‐inflammatory	  benefit	  (Gomez	  et	  al.,	  2011).	  	   	   Hutnick	  et	  al.	  (2005)	  were	  interested	  in	  the	  effect	  of	  a	  6-­‐month	  exercise	  intervention	  on	  both	  inflammatory	  and	  immune	  function	  markers	  in	  post-­‐treatment	  breast	  cancer	  patients.	  	  The	  study	  consisted	  of	  two	  groups,	  an	  exercise	  group	  (n=28)	  and	  a	  non-­‐exercise	  control	  group	  (n=21).	  	  Subjects	  in	  the	  exercise	  group	  underwent	  combined	  aerobic	  and	  resistance	  training	  sessions	  three	  times	  per	  week,	  but	  twelve	  of	  these	  subjects	  participated	  in	  the	  exercise	  training	  for	  only	  three	  months	  instead	  of	  the	  full	  six	  months.	  	  The	  exercise	  group	  had	  higher	  but	  non-­‐significant	  levels	  of	  IL-­‐6	  throughout	  the	  exercise	  program	  compared	  to	  the	  control	  group.	  	  Although	  there	  were	  no	  significant	  changes	  found	  in	  cytokines	  throughout	  the	  exercise	  intervention,	  there	  were	  greater	  levels	  of	  lymphocytes,	  such	  as	  CD4+	  cell	  activation,	  found	  in	  the	  exercise	  group.	  	  These	  findings	  suggest	  that	  a	  moderate	  intensity	  exercise	  program	  may	  result	  in	  an	  increased	  immune	  system	  function	  in	  breast	  cancer	  survivors	  (Hutnick	  et	  al.,	  2005).	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   While	  some	  studies	  have	  found	  no	  changes	  in	  inflammatory	  markers	  due	  to	  an	  exercise	  intervention,	  other	  studies	  have.	  	  Fairey	  et	  al.	  (2005)	  found	  exercise-­‐induced	  changes	  in	  CRP	  in	  postmenopausal	  breast	  cancer	  survivors.	  	  Fifty-­‐three	  breast	  cancer	  survivors	  were	  randomly	  assigned	  to	  an	  exercise	  group	  (n=25)	  or	  control	  group	  (n=28).	  	  The	  exercise	  group	  trained	  3	  times	  per	  week	  for	  15	  weeks	  on	  cycle	  ergometers.	  	  At	  the	  end	  of	  the	  exercise	  intervention,	  CRP	  decreased	  by	  1.39	  mg/L	  in	  the	  exercise	  group	  whereas	  it	  increased	  0.10	  mg/L	  in	  the	  control	  group.	  	  Although	  the	  mean	  between	  group	  change	  in	  CRP	  was	  -­‐1.49	  mg/L,	  the	  exercise	  training	  was	  found	  to	  have	  a	  change	  in	  CRP	  that	  only	  approached	  significance	  (p	  =	  .066).	  	  According	  to	  the	  authors,	  proposed	  mechanisms	  for	  the	  change	  found	  in	  CRP	  included	  alterations	  in:	  cytokine	  production	  by	  blood	  mononuclear	  cells,	  NK	  cell	  cytotoxic	  activity,	  oxidized	  low-­‐density	  lipoprotein	  cholesterol,	  intra-­‐abdominal	  fat,	  insulin	  resistance,	  nitric	  oxide,	  antioxidants,	  and	  leukocyte	  adhesion	  molecules	  (Fairey	  et	  al.,	  2005b).	  	   	   Janelsins	  et	  al.	  (2011)	  assessed	  the	  effects	  of	  a	  12-­‐week	  moderately	  intense	  Tai	  Chi	  Chuan	  (traditional	  Chinese	  martial	  art)	  intervention	  on	  breast	  cancer	  survivors.	  	  Post-­‐treatment	  breast	  cancer	  patients	  were	  randomized	  into	  the	  Tai	  Chi	  Chuan	  exercise	  group	  or	  a	  psychosocial	  support	  therapy	  control	  group.	  	  Subjects	  in	  the	  Tai	  Chi	  Chuan	  group	  met	  for	  60	  minutes	  3	  times	  per	  week.	  	  Breast	  cancer	  survivors	  who	  participated	  in	  the	  Tai	  Chi	  Chuan	  were	  found	  to	  have	  non-­‐significant	  decreases	  in	  IL-­‐6	  along	  with	  non-­‐significant	  increases	  in	  IL-­‐2.	  	  The	  researchers	  found	  that	  changes	  in	  fat-­‐free	  mass	  were	  positively	  correlated	  with	  changes	  in	  IL-­‐6	  and	  negatively	  correlated	  with	  changes	  in	  IL-­‐2.	  	  As	  fat-­‐free	  mass	  increased,	  IL-­‐6	  also	  increased	  but	  IL-­‐2	  decreased.	  	  This	  lead	  the	  authors	  to	  believe	  that	  the	  elevated	  IL-­‐6	  levels	  were	  positive	  markers	  of	  the	  reduction	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in	  fat	  mass	  that	  resulted	  from	  the	  moderate-­‐intensity	  form	  of	  exercise	  (Janelsins	  et	  al.,	  2011).	  	   	   Sixty-­‐eight	  breast	  cancer	  survivors	  were	  randomized	  into	  either	  a	  6-­‐month	  aerobic	  exercise	  intervention	  (n	  =	  36)	  or	  usual	  care	  (n	  =	  32)	  in	  a	  study	  conducted	  by	  Jones	  et	  al.	  (2012).	  	  At	  baseline,	  the	  study	  found	  that	  both	  IL-­‐6	  and	  CRP	  were	  positively	  correlated	  with	  percent	  body	  fat,	  body	  weight,	  and	  BMI,	  and	  inversely	  correlated	  with	  pedometer	  steps	  per	  day.	  	  These	  results	  suggest	  that	  IL-­‐6	  and	  CRP	  were	  associated	  with	  higher	  adiposity	  as	  well	  as	  lower	  levels	  of	  physical	  activity	  at	  baseline.	  	  After	  6	  months,	  plasma	  concentrations	  of	  IL-­‐6,	  CRP,	  and	  TNF-­‐α	  did	  not	  differ	  between	  the	  exercise	  and	  usual	  care	  groups.	  	  However,	  secondary	  analyses	  showed	  a	  significant	  decrease	  in	  IL-­‐6	  among	  exercisers	  who	  exercised	  at	  least	  120	  minutes	  per	  week	  compared	  with	  those	  who	  exercised	  less	  than	  120	  minutes	  per	  week.	  	  The	  authors	  also	  reported	  a	  borderline	  significant	  correlation	  between	  change	  in	  percent	  body	  fat	  and	  change	  in	  CRP	  in	  women	  randomized	  to	  exercise	  (p	  =	  0.069).	  	  Poor	  adherence	  to	  the	  exercise	  intervention	  may	  have	  impacted	  the	  results	  since	  women	  who	  met	  at	  least	  80%	  of	  the	  exercise	  goal	  showed	  significant	  decreases	  in	  IL-­‐6.	  	  The	  authors	  concluded	  by	  stating	  potential	  mechanisms	  through	  which	  physical	  activity	  may	  reduce	  inflammation.	  	  These	  mechanisms	  include:	  anti-­‐inflammatory	  cytokine	  release	  during	  exercise,	  effects	  of	  muscle-­‐derived	  IL-­‐6,	  reductions	  in	  adipose	  tissue,	  and	  inhibition	  of	  TNF-­‐α	  production	  by	  epinephrine	  (Jones	  et	  al.,	  2012).	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Summary	  Overview	  of	  the	  gaps	  in	  the	  current	  literature	  and	  exercise	  prescription	  guidelines	  for	  cancer	  survivors	  	   	   	  	   	   Given	  that	  exercise	  modulates	  the	  immune	  system	  in	  healthy	  individuals,	  research	  considering	  clinical	  populations	  for	  which	  the	  immune	  system	  has	  a	  role,	  such	  as	  breast	  cancer	  survivors,	  is	  of	  importance.	  	  Although	  there	  are	  specific	  risks	  related	  to	  cancer	  treatments	  that	  need	  to	  be	  considered	  when	  survivors	  exercise,	  there	  seems	  to	  be	  consistent	  evidence	  that	  exercise	  is	  safe	  and	  well	  tolerated	  without	  adverse	  effects	  in	  breast	  cancer	  survivors	  (Schmitz	  et	  al.,	  2010).	  	  Few	  studies	  have	  examined	  markers	  of	  inflammation	  in	  breast	  cancer	  survivors,	  and	  even	  fewer	  studies	  have	  investigated	  the	  inflammatory	  response	  to	  exercise	  in	  this	  population	  (Seruga	  et	  al.,	  2008).	  	  The	  majority	  of	  studies	  that	  have	  explored	  the	  relationship	  between	  exercise	  and	  markers	  of	  inflammation	  in	  breast	  cancer	  survivors	  have	  only	  focused	  on	  the	  inflammatory	  response	  due	  to	  long-­‐term	  exercise	  interventions	  in	  these	  patients.	  	  Most	  exercise	  oncology	  studies	  have	  only	  observed	  pre-­‐	  and	  post-­‐levels	  of	  inflammatory	  markers	  in	  response	  to	  an	  exercise	  intervention,	  and	  not	  the	  effect	  of	  an	  acute	  bout	  of	  exercise	  on	  these	  markers	  in	  breast	  cancer	  survivors.	  	  	   	   It	  is	  necessary	  to	  observe	  the	  magnitude	  and	  temporal	  response	  of	  cytokines	  in	  order	  to	  understand	  the	  inflammatory	  response	  to	  exercise.	  	  Exercise	  prescriptions	  for	  breast	  cancer	  survivors	  are	  modeled	  after	  those	  for	  healthy	  populations	  (Schmitz	  et	  al.,	  2010).	  	  It	  is	  currently	  unknown	  whether	  breast	  cancer	  survivors	  have	  similar	  exercise-­‐induced	  inflammatory	  responses	  as	  healthy	  individuals.	  	  The	  acute	  effects	  of	  exercise	  need	  to	  be	  explored	  in	  order	  to	  examine	  the	  more	  direct	  relationship	  between	  exercise	  and	  the	  role	  of	  inflammation	  in	  breast	  cancer	  survivors.	  	  Understanding	  the	  more	  acute	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effects	  of	  exercise	  will	  allow	  for	  the	  enhancement	  of	  exercise	  prescription	  guidelines,	  as	  well	  as	  the	  time	  course	  needed	  before	  prescribing	  the	  next	  exercise	  session.	  	  This	  understanding	  will	  be	  helpful	  in	  order	  for	  these	  patients	  to	  fully	  recover	  and	  receive	  the	  maximal	  health	  benefits	  of	  exercise	  without	  increasing	  the	  risk	  of	  further	  illness.	  	  	  	  	  	  






	   Data	  from	  18	  subjects	  were	  analyzed	  in	  this	  retrospective	  study.	  	  The	  recruitment	  process	  for	  the	  study	  was	  completely	  voluntary	  as	  subjects	  were	  made	  aware	  of	  the	  study	  through	  contact	  by	  a	  member	  of	  the	  research	  team	  as	  well	  as	  through	  fliers.	  	  Subjects	  were	  recruited	  into	  a	  breast	  cancer	  survivor	  and	  a	  healthy	  control	  group:	  each	  consisting	  of	  9	  subjects.	  	  Attempts	  were	  made	  to	  pair	  subjects	  in	  the	  control	  group	  with	  subjects	  in	  the	  breast	  cancer	  survivor	  group	  based	  on	  age	  and	  physical	  activity	  level.	  	  Recruitment	  sites	  for	  subjects	  in	  the	  breast	  cancer	  survivor	  group	  included	  the	  Medical	  Oncology	  clinic	  and	  the	  Radiation	  Oncology	  clinic	  at	  the	  North	  Carolina	  Cancer	  Hospital	  as	  well	  as	  from	  the	  waitlist	  of	  the	  Get	  REAL	  and	  HEEL	  Breast	  Cancer	  Program	  in	  the	  Department	  of	  Exercise	  and	  Sport	  Science	  at	  the	  University	  of	  North	  Carolina	  at	  Chapel	  Hill.	  	  The	  control	  group	  consisted	  of	  subjects	  recruited	  from	  the	  staff,	  faculty,	  and	  student	  populations	  at	  UNC-­‐Chapel	  Hill,	  as	  well	  as	  from	  across	  the	  Triangle	  region	  of	  North	  Carolina	  (Raleigh,	  Durham,	  Chapel	  Hill,	  and	  surrounding	  areas).	  	  Approval	  from	  the	  Institutional	  Review	  Boards	  in	  both	  the	  Department	  of	  Exercise	  and	  Sport	  Science	  and	  School	  of	  Medicine	  at	  UNC-­‐Chapel	  Hill,	  along	  with	  approval	  from	  the	  Protocol	  Review	  Committee	  in	  the	  Lineberger	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Comprehensive	  Cancer	  Center	  at	  UNC-­‐CH,	  was	  acquired	  before	  progressing	  with	  the	  recruitment	  of	  subjects.	  All	  subjects	  in	  both	  groups	  were	  between	  the	  ages	  of	  40	  to	  70	  years	  old,	  were	  either	  post-­‐menopausal	  or	  had	  not	  experienced	  a	  menstrual	  period	  for	  approximately	  1	  year	  before	  enrollment,	  and	  were	  not	  normal	  users	  of	  anti-­‐inflammatory	  medications.	  	  Additional	  inclusion	  criteria	  for	  participation	  in	  the	  breast	  cancer	  survivor	  group	  were	  as	  follows:	  1)	  Confirmed	  diagnosis	  of	  Stage	  I,	  II,	  or	  III	  invasive	  breast	  cancer;	  2)	  Had	  received	  chemotherapy;	  3)	  Must	  had	  completed	  all	  major	  cancer	  treatments	  3-­‐6	  months	  prior	  to	  enrollment.	  	  Additional	  inclusion	  criteria	  for	  participation	  in	  the	  control	  group	  were	  as	  follows:	  1)	  No	  history	  of	  cancer	  diagnosis	  or	  treatment;	  2)	  Were	  free	  from	  musculoskeletal	  and	  cardiovascular	  disease	  that	  would	  make	  participation	  in	  aerobic	  exercise	  unsafe;	  3)	  No	  participation	  in	  organized	  physical	  activity	  for	  at	  least	  1	  year	  prior	  to	  enrollment.	  	  Subjects	  were	  screened	  for	  exclusion	  based	  on	  the	  criteria	  put	  forth	  by	  the	  American	  College	  of	  Sports	  Medicine	  (ACSM)	  as	  contraindications	  to	  exercise	  testing	  (Whaley	  et	  al.,	  2006-­‐	  ACSM’s	  Guidelines	  for	  Exercise	  Testing	  and	  Prescription).	  
	  
Instrumentation	  
	   Height	  was	  measured	  to	  the	  nearest	  0.01	  cm	  using	  a	  Portable	  stadiometer	  (Perspective	  Enterprises,	  Portage,	  MI	  USA),	  and	  weight	  was	  measured	  to	  the	  nearest	  0.1	  kg	  using	  a	  Mechanical	  scale	  (Detecto,	  Webb	  City,	  MO	  USA).	  	  A	  Discovery	  Dual	  Energy	  X-­‐Ray	  Absorption	  (DEXA)	  scanner	  (Hologic,	  Inc.,	  Bedford,	  MA	  USA)	  was	  used	  in	  order	  to	  assess	  percent	  body	  fat.	  	  A	  medical	  history	  questionnaire	  (Department	  of	  Exercise	  and	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Sport	  Science	  Medical	  History	  form)	  was	  also	  used	  to	  record	  information	  about	  each	  subject’s	  medical	  history,	  race,	  age,	  physical	  activity	  level	  over	  the	  past	  year,	  menopausal	  status,	  and	  cancer	  treatment	  type	  (for	  subjects	  in	  the	  breast	  cancer	  survivor	  group	  only).	  	  Also,	  the	  medical	  history	  questionnaire	  was	  used	  by	  a	  research	  team	  member	  authorized	  to	  do	  physical	  evaluations	  for	  exercise	  testing	  prior	  to	  subjects	  participating	  in	  the	  study.	  	  This	  was	  used	  in	  concert	  with	  the	  resting	  EKG	  and	  the	  physical	  exam	  to	  determine	  if	  the	  subjects	  were	  cleared	  to	  participate	  in	  the	  study.	  	  	  Heart	  rate	  was	  assessed	  via	  Pacer	  Polar	  heart	  rate	  monitor	  (Polar	  Electro	  Inc.,	  Lake	  Success,	  NY	  USA).	  	  Blood	  pressure	  was	  assessed	  via	  Diagnostix	  700	  aneroid	  sphygmomanometer	  (American	  Diagnostics	  Corporation,	  Hauppauge,	  NY	  USA)	  and	  Litmann	  stethoscope	  (3m,	  St.	  Paul,	  MN	  USA)	  during	  rest	  and	  exercise.	  	  A	  resting	  electrocardiogram	  (EKG)	  was	  performed	  prior	  to	  testing	  and	  EKG	  monitoring	  was	  continued	  during	  exercise	  using	  a	  GE	  CASE	  Cardiosoft	  V.	  6.6	  ECG	  diagnostic	  system	  (General	  Electric,	  Palatine,	  IL	  USA).	  	  A	  Parvo	  Medics	  TrueMax	  2400	  Metabolic	  System	  (Parvo	  Medics,	  Salt	  Lake	  City,	  UT	  USA)	  was	  used	  for	  the	  assessment	  of	  Cardiopulmonary	  function	  (VO2peak	  ).	  	  Both	  the	  VO2peak	  test	  and	  the	  acute	  aerobic	  exercise	  bout	  consisted	  of	  cycling	  using	  a	  Lode	  electronically	  braked	  cycle	  ergometer	  (Lode,	  Gronigen,	  The	  Netherlands).	  	  The	  Borg’s	  6-­‐20	  Rate	  of	  Perceived	  Exertion	  (RPE)	  scale	  was	  used	  to	  measure	  RPE.	  The	  following	  instruments	  were	  used	  for	  the	  assessment	  of	  blood	  sampling	  procedures	  as	  well	  as	  markers	  of	  inflammation	  and	  immune	  system	  function.	  	  Whole	  blood	  samples	  were	  collected	  in	  K3EDTA	  Vaccutainer	  tubes.	  	  An	  IEC	  Centra-­‐8R	  refrigerated	  centrifuge	  (International	  Equipment	  Company,	  Needham	  Heights,	  MA	  USA)	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were	  used	  in	  order	  to	  isolate	  the	  plasma	  component	  of	  the	  whole	  blood	  samples.	  	  For	  the	  determination	  of	  plasma	  volume	  shifts,	  hematocrit	  and	  hemoglobin	  were	  measured	  from	  complete	  blood	  count	  data	  using	  a	  COULTER	  Ac•T	  diff	  Hematology	  Analyzer	  (Beckman	  Coulter,	  Inc.,	  Brea,	  CA	  USA).	  	  NK	  cell	  count	  was	  analyzed	  using	  a	  CyAn	  3	  laser/9	  color	  flow	  cytometer	  (Beckman	  Coulter,	  Inc.,	  Brea,	  CA	  USA).	  	  Flow	  cytometry	  data	  was	  viewed	  and	  analyzed	  using	  Summit	  4.3	  software	  (Dako	  North	  America,	  Inc.,	  Carpinteria,	  CA	  USA).	  	  Enzyme-­‐linked	  immunosorbant	  assay	  (ELISA)	  kits	  (Rocky	  Mountain	  Diagnostics,	  Inc,	  Colorado	  Springs,	  CO	  USA;	  R&D	  Systems,	  Minneapolis,	  MN	  USA)	  were	  used	  to	  measure	  markers	  of	  inflammation	  (TNF-­‐	  α,	  CRP,	  and	  IL-­‐10).	  	  In	  order	  to	  read	  the	  ELISA	  assays,	  a	  Finstruments	  347	  microplate	  reader	  and	  Spectra	  software	  analysis	  (MTX	  Lab	  Systems	  Inc.,	  Vienna,	  VA	  USA)	  was	  used.	  	  
	  
Procedures	  
	   	   Due	  to	  the	  nature	  if	  this	  retrospective	  study,	  data	  were	  already	  collected	  as	  part	  of	  a	  previous	  dissertation.	  	  All	  procedures	  about	  the	  exercise	  protocol,	  blood	  sampling,	  and	  NK	  cell	  analysis	  using	  flow	  cytometry	  can	  be	  found	  in	  the	  dissertation	  of	  Dr.	  Elizabeth	  Evans,	  2012	  (UNC-­‐CH).	  	  This	  study	  analyzed	  the	  blood	  samples	  from	  Dr.	  Evans	  dissertation	  study	  in	  order	  to	  evaluate	  the	  inflammatory	  response	  of	  breast	  cancer	  survivors	  due	  to	  an	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise.	  	   	   All	  subjects	  visited	  the	  laboratory	  on	  three	  different	  occasions.	  	  Prior	  to	  each	  visit	  to	  the	  laboratory,	  subjects	  were	  asked	  to	  follow	  a	  set	  of	  pre-­‐assessment	  guidelines.	  	  These	  included	  the	  maintenance	  of	  adequate	  hydration,	  no	  eating	  for	  at	  least	  two	  hours	  prior	  to	  testing,	  no	  exercise	  or	  caffeine	  intake	  for	  at	  least	  12	  hours	  prior	  to	  testing,	  and	  
	   49	  
no	  alcohol	  consumption	  for	  at	  least	  48	  hours	  prior	  to	  testing.	  	  All	  subjects	  included	  in	  this	  study	  were	  required	  to	  have	  a	  physical	  screening	  by	  either	  a	  physician	  or	  other	  certified	  professional,	  complete	  a	  medical	  history	  questionnaire,	  and	  undergo	  a	  12-­‐lead	  resting	  electrocardiogram.	  	  All	  visits	  to	  the	  laboratory	  took	  place	  in	  either	  the	  Integrative	  Exercise	  Oncology	  Research	  Laboratory	  (IEORL)	  and/or	  in	  the	  Applied	  Physiology	  Laboratory	  (APL)	  in	  the	  Department	  of	  Exercise	  and	  Sport	  Science	  at	  UNC-­‐CH.	  	  In	  order	  to	  reduce	  the	  potential	  for	  diurnal	  variation	  in	  the	  study	  variables,	  the	  acute	  exercise	  session	  (i.e.,	  the	  one	  where	  the	  blood	  samples	  were	  taken)	  began	  between	  7:00-­‐10:00	  am.	  	  Keeping	  similar	  times	  of	  day	  when	  subjects	  reported	  to	  the	  lab	  allowed	  for	  more	  controlled	  measurements	  of	  inflammatory	  markers.	  
	   	   The	  following	  is	  an	  overview	  of	  each	  visit	  to	  the	  laboratory.	  	  The	  three	  laboratory	  visits	  will	  be	  further	  broken	  down	  in	  the	  proceeding	  text.	  	  Visit	  1	  consisted	  of	  medical	  and	  physical	  screening,	  the	  assessment	  of	  peak	  aerobic	  capacity	  on	  the	  cycle	  ergometer,	  and	  an	  orientation	  to	  the	  study.	  	  Visit	  2	  included	  each	  subject	  performing	  a	  moderate	  aerobic	  bout	  of	  exercise	  for	  30	  minutes	  on	  the	  cycle	  ergometer	  at	  60%	  of	  their	  VO2peak.	  	  During	  this	  laboratory	  visit,	  blood	  samples	  were	  collected	  pre-­‐exercise	  (baseline),	  immediately	  post-­‐exercise,	  and	  2	  hours	  post-­‐exercise.	  	  Visit	  3	  only	  included	  the	  collection	  of	  one	  blood	  sample	  from	  each	  subject	  24	  hours	  post-­‐exercise.	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Fig	  1.	  Blood	  sampling	  timeline	  
	   	  Visit	  1:	  Medical/Physical	  Screening	  and	  VO2peak	  Test	  
	   	   The	  first	  visit	  to	  the	  laboratory	  consisted	  of	  all	  subjects	  completing	  a	  comprehensive	  medical	  history	  form	  and	  undergoing	  both	  a	  physical	  exam	  and	  12-­‐lead	  resting	  electrocardiogram.	  	  Subjects	  received	  information	  regarding	  potential	  risks	  of	  participation	  in	  the	  study,	  a	  description	  of	  the	  study	  protocol,	  and	  were	  asked	  to	  sign	  informed	  consent	  documentation.	  	  Age,	  height,	  body	  mass,	  and	  race	  were	  recorded	  for	  all	  subjects,	  and	  height	  and	  body	  mass	  were	  used	  to	  calculate	  body	  mass	  index	  (BMI).	  	  Percent	  body	  fat	  was	  also	  measured	  using	  a	  Dual	  Energy	  X-­‐ray	  Absorption	  (DEXA)	  scanner.	  	  Cancer	  treatment	  type	  was	  documented	  for	  subjects	  in	  the	  breast	  cancer	  survivor	  group.	  VO2peak	  was	  also	  measured	  during	  the	  first	  visit	  to	  the	  laboratory.	  	  The	  VO2peak	  test	  was	  performed	  on	  an	  electronically	  braked	  cycle	  ergometer	  using	  the	  Astrand	  Cycle	  Ergometer	  Maximal	  Test	  Protocol.	  	  VO2peak	  was	  used	  to	  assess	  peak	  aerobic	  capacity	  in	  order	  to	  estimate	  the	  submaximal	  workload	  that	  all	  subjects	  would	  perform	  during	  visit	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2.	  	  The	  VO2peak	  test	  began	  with	  the	  collection	  of	  resting	  metabolic	  data	  as	  subjects	  sat	  quietly	  for	  3	  minutes	  on	  the	  cycle	  ergometer.	  	  The	  first	  stage	  of	  the	  test	  started	  with	  subjects	  cycling	  at	  50	  Watts	  for	  3	  minutes.	  	  Each	  stage	  was	  3	  minutes	  long,	  and	  at	  the	  end	  of	  each	  stage	  workload	  was	  increased	  by	  25	  Watts	  until	  volitional	  fatigue.	  	  Each	  subject’s	  VO2peak	  was	  the	  highest	  VO2	  measured	  by	  the	  metabolic	  system	  during	  the	  last	  stage	  obtained	  by	  the	  subject.	  	  The	  corresponding	  workload	  on	  the	  cycle	  ergometer	  at	  each	  subject’s	  VO2peak	  was	  recorded	  as	  the	  subject’s	  peak	  workload.	  	  	  The	  subject	  pedaled	  at	  a	  low	  workload	  (<20	  Watts)	  once	  the	  VO2peak	  test	  was	  complete,	  with	  continued	  blood	  pressure	  and	  EKG	  monitoring	  until	  subjects	  returned	  to	  near-­‐baseline	  levels.	  	  Heart	  rate,	  expired	  gases,	  rating	  of	  perceived	  exertion	  (RPE)	  (6-­‐20	  Borg	  scale),	  and	  12-­‐lead	  ECG	  monitoring	  were	  performed	  throughout	  the	  test.	  	  Both	  heart	  rate	  and	  RPE	  were	  recorded	  at	  the	  end	  of	  every	  minute	  during	  the	  VO2peak	  test.	  	  Workloads	  at	  60%	  VO2peak	  for	  all	  subjects	  were	  estimated	  by	  regressing	  VO2	  values	  for	  each	  stage	  against	  corresponding	  workloads	  for	  that	  stage	  (See	  Figure	  2	  below	  for	  an	  example).	  	  Fig	  2.	  Example	  regression	  for	  determining	  workload	  corresponding	  to	  60%	  of	  VO2peak	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Visit	  2:	  Acute	  Aerobic	  Exercise	  Session	  
	   	   An	  acute	  bout	  of	  intermittent,	  moderate	  exercise	  was	  performed	  by	  all	  subjects	  on	  a	  cycle	  ergometer	  for	  30	  minutes	  at	  an	  intensity	  corresponding	  to	  60%	  of	  each	  subject’s	  VO2peak.	  	  A	  discontinuous	  exercise	  protocol	  was	  used	  to	  ensure	  that	  all	  subjects	  would	  be	  capable	  of	  completing	  the	  exercise	  session.	  	  Subjects	  underwent	  30	  minutes	  of	  exercise	  in	  a	  43.5-­‐minute	  period,	  alternating	  ten	  3-­‐minute	  intervals	  of	  exercise	  with	  1.5	  minutes	  of	  rest.	  	   	   All	  subjects	  rested	  in	  the	  supine	  position	  for	  approximately	  20	  minutes	  at	  the	  beginning	  of	  visit	  2,	  while	  a	  catheter	  was	  inserted	  into	  an	  antecubital	  vein	  in	  the	  arm	  for	  blood	  sampling.	  	  The	  three-­‐syringe	  technique	  was	  used	  for	  blood	  sampling.	  	  A	  small	  amount	  of	  blood	  was	  drawn	  for	  the	  first	  blood	  draw	  to	  remove	  “waste,”	  such	  as	  saline,	  from	  the	  catheter.	  	  The	  second	  blood	  draw	  contained	  the	  actual	  blood	  sample.	  	  Finally,	  1.5	  mL	  of	  sterile	  saline	  was	  injected	  to	  keep	  the	  catheter	  patent	  between	  blood	  sampling.	  	  	  	   	   Pre-­‐exercise	  (baseline)	  blood	  samples	  were	  drawn	  into	  K3EDTA	  Vacutainer	  tubes	  for	  the	  measurements	  of	  NK	  cell	  counts	  and	  markers	  of	  inflammation.	  	  Subjects	  sat	  quietly	  on	  a	  cycle	  ergometer	  for	  3	  minutes	  after	  the	  pre-­‐exercise	  blood	  sample	  was	  taken,	  while	  resting	  metabolic	  data	  was	  collected.	  	  All	  subjects	  then	  warmed	  up	  with	  light	  pedaling	  at	  about	  30	  Watts	  on	  a	  cycle	  ergometer	  for	  4-­‐5	  minutes.	  	  Subjects	  were	  also	  able	  to	  stretch	  the	  lower	  body	  in	  a	  comfortable	  manner	  before	  the	  30-­‐minute	  moderate-­‐intensity	  exercise	  bout	  began.	  	  Heart	  and	  RPE	  were	  documented	  at	  the	  end	  of	  every	  3-­‐minute	  period	  of	  exercise,	  while	  expired	  gases	  were	  recorded	  during	  the	  first,	  third,	  seventh,	  and	  tenth	  exercise	  intervals.	  	  Workload	  was	  modified	  if	  needed	  in	  order	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to	  make	  sure	  each	  subject	  was	  exercising	  as	  close	  to	  60%	  VO2peak	  as	  possible.	  	  Subjects	  were	  informed	  to	  carefully	  dismount	  from	  the	  cycle	  ergometer	  immediately	  at	  the	  end	  of	  the	  exercise	  bout	  and	  return	  to	  the	  supine	  position.	  	  Blood	  sampling	  for	  the	  immediately-­‐post	  exercise	  time	  period	  was	  carried	  out	  in	  the	  same	  nature	  as	  described	  before.	  	  Subjects	  then	  rested	  comfortably	  in	  the	  laboratory	  until	  a	  final	  blood	  sample	  during	  visit	  2	  was	  obtained	  at	  2	  hours	  post-­‐exercise	  using	  the	  same	  techniques	  as	  the	  two	  previous	  blood	  samples.	  	  Subjects	  were	  allowed	  to	  drink	  water	  during	  the	  2-­‐hour	  resting	  period,	  but	  no	  food	  or	  other	  beverages	  could	  be	  ingested.	  	  At	  the	  end	  of	  visit	  2,	  each	  subject’s	  catheter	  was	  removed	  followed	  by	  bandaging	  of	  the	  arm.	  Visit	  3:	  	  24-­‐hour	  Follow-­‐up	  Session	  
	   	   A	  resting	  blood	  sample	  was	  taken	  from	  each	  subject	  24	  hours	  after	  the	  acute	  aerobic	  exercise	  bout.	  	  Using	  a	  standard	  venipuncture	  technique,	  the	  sample	  of	  blood	  was	  drawn	  from	  an	  antecubital	  vein.	  	  	  	  	  Calculation	  of	  Plasma	  Volume	  Shifts	  	   	   Plasma	  volume	  shifts	  were	  measured	  in	  order	  to	  account	  for	  the	  effect	  of	  exercise	  and	  posture	  on	  fluid	  shifts	  throughout	  the	  study,	  which	  may	  affect	  concentrations	  of	  leukocytes	  and	  markers	  of	  inflammation.	  	  Plasma	  volume	  shifts	  were	  calculated	  using	  the	  equation	  by	  Dill	  and	  Costill	  (Dill	  and	  Costill,	  1974).	  	  The	  calculation	  of	  plasma	  volume	  shifts	  used	  the	  hematocrit	  and	  hemoglobin	  values	  obtained	  from	  the	  whole	  blood	  samples	  taken	  pre-­‐exercise,	  immediately	  post-­‐exercise,	  2	  hours	  post-­‐exercise,	  and	  24	  hours	  post-­‐exercise.	  	  Hematocrit	  and	  hemoglobin	  were	  measured	  from	  complete	  blood	  count	  data	  using	  an	  automated	  hematology	  analyzer.	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Determination	  of	  Inflammatory	  Markers	  The	  subjects’	  plasma	  samples	  stored	  at	  an	  -­‐80	  degree	  Celsius	  freezer	  from	  the	  subjects	  who	  participated	  in	  Dr.	  Evans	  dissertation	  study	  will	  be	  used	  for	  the	  analyses	  of	  cytokines	  in	  this	  study.	  	  Markers	  of	  inflammation	  were	  measured	  from	  the	  stored	  plasma	  via	  enzyme-­‐linked	  immunosorbent	  assay	  (ELISA)	  procedures.	  	  To	  ensure	  quality	  control,	  all	  samples	  were	  measured	  in	  duplicate.	  	  C-­‐reactive	  protein	  was	  measured	  using	  a	  sandwich	  enzyme	  immunoassay	  kit	  with	  a	  sensitivity	  of	  28.6	  pg/mL.	  	  The	  manufacturer	  reported	  mean	  intra-­‐assay	  coefficient	  of	  variation	  for	  C-­‐reactive	  protein	  was	  2.73%,	  and	  the	  reported	  mean	  inter-­‐assay	  coefficient	  of	  variation	  was	  4.33%.	  	  TNF-­‐α	  was	  measured	  using	  a	  sandwich	  enzyme	  immunoassay	  kit	  with	  a	  sensitivity	  of	  5.0	  pg/mL.	  	  The	  manufacturer	  reported	  mean	  intra-­‐assay	  coefficient	  of	  variation	  for	  TNF-­‐α	  was	  7.70%,	  and	  the	  reported	  mean	  inter-­‐assay	  coefficient	  of	  variation	  was	  8.10%.	  	  IL-­‐10	  was	  measured	  using	  a	  sandwich	  enzyme	  immunoassay	  kit	  with	  a	  sensitivity	  of	  1.0	  pg/mL.	  	  The	  manufacturer	  reported	  mean	  intra-­‐assay	  coefficient	  of	  variation	  for	  IL-­‐10	  was	  3.20%,	  and	  the	  reported	  mean	  inter-­‐assay	  coefficient	  of	  variation	  was	  5.60%.	  	  All	  manufacturer	  reported	  values	  were	  obtained	  from	  the	  Abnova	  Corporation,	  2013.	  	  The	  microplate	  reader	  used	  for	  the	  ELISA	  assays	  had	  a	  manufacturer	  reported	  accuracy	  of	  ±	  1%	  and	  a	  coefficient	  of	  variability	  <0.5%	  with	  a	  reported	  spectral	  range	  from	  340-­‐750nm.	  	  The	  manufacturer	  reported	  values	  for	  the	  Finstruments	  347	  microplate	  reader	  were	  gathered	  from	  MTX	  Lab	  Systems,	  Inc.	  (2013).	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Determination	  of	  Natural	  Killer	  cell	  counts	  	   NK	  cell	  counts	  were	  analyzed	  using	  flow	  cytometry.	  	  Whole	  blood	  samples	  were	  stained	  using	  fluorescently-­‐labeled	  monoclonal	  antibodies	  for	  the	  cell	  surface	  markers	  CD3,	  CD16,	  and	  CD56.	  Fluorescent	  staining	  was	  done	  in	  order	  to	  identify	  the	  proportion	  of	  lymphocytes	  that	  express	  the	  CD3-­‐CD16+CD56+	  phenotype,	  which	  is	  characteristic	  of	  NK	  cells.	  	  Samples	  were	  fixed	  in	  a	  1%	  paraformaldehyde	  solution	  and	  were	  analyzed	  within	  24	  hours	  of	  preparation	  using	  a	  flow	  cytometer.	  	  Absolute	  NK	  cell	  counts	  were	  calculated	  by	  multiplying	  total	  lymphocyte	  counts	  by	  the	  NK	  cell	  proportions.	  
	  
Data	  Analysis	  Sample	  Size	  Calculation	  	   	   For	  this	  study,	  the	  desired	  sample	  size	  was	  the	  number	  of	  subjects	  per	  group	  needed	  to	  detect	  statistical	  significance	  between	  markers	  of	  inflammation	  with	  a	  level	  of	  power	  at	  .80	  and	  an	  alpha	  level	  of	  0.05.	  	  Estimation	  of	  sample	  size	  for	  the	  current	  study	  was	  based	  on	  the	  evaluation	  of	  IL-­‐10	  response	  to	  an	  acute	  maximal	  exercise	  test	  from	  pre-­‐exercise	  (baseline)	  to	  immediately	  post-­‐exercise	  in	  patients	  with	  major	  depressive	  disorder	  (Boettger	  et	  al.,	  2010).	  	  A	  power	  and	  sample	  size	  calculation	  (PS)	  program	  was	  used	  to	  calculate	  the	  current	  study’s	  estimated	  sample	  size	  (Dupont	  and	  Plummer,	  PS	  version	  3.0,	  2009).	  	  The	  sample	  size	  calculation	  was	  used	  to	  examine	  the	  number	  of	  subjects	  needed	  to	  reach	  statistical	  significance	  in	  the	  response	  of	  inflammatory	  markers	  to	  an	  acute	  bout	  of	  exercise	  based	  on	  the	  results	  of	  the	  study	  conducted	  by	  Boettger	  et	  al.	  (2010).	  	  The	  sample	  size	  calculation	  was	  focused	  on	  a	  continuous	  response	  variable	  from	  matched	  pairs	  of	  study	  subjects.	  	  Prior	  data	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indicates	  that	  the	  difference	  in	  the	  response	  of	  matched	  pairs	  is	  normally	  distributed	  with	  standard	  deviation	  of	  1.	  	  If	  the	  true	  difference	  in	  the	  mean	  response	  of	  matched	  pairs	  was	  0.8,	  the	  current	  study	  needed	  14	  pairs	  of	  subjects	  (14	  subjects	  paired	  against	  one	  another)	  to	  be	  able	  to	  reject	  the	  null	  hypothesis	  that	  this	  response	  difference	  was	  zero	  with	  a	  power	  of	  .80.	  	  A	  sample	  size	  of	  14	  pairs	  of	  subjects	  was	  most	  likely	  an	  underestimate	  of	  the	  number	  of	  subjects	  needed	  due	  to	  the	  use	  of	  mean	  data	  instead	  of	  raw	  data	  in	  the	  calculation	  of	  sample	  size.	  	  Therefore,	  the	  current	  study	  was	  “under-­‐powered”	  due	  to	  there	  only	  being	  9	  pairs	  of	  subjects	  included.	  	  Statistical	  Analysis	  	   All	  data	  in	  the	  current	  study	  was	  analyzed	  using	  SPSS	  Statistics	  version	  20.0.	  	  The	  alpha	  level	  was	  set	  a	  priori	  for	  all	  statistical	  analyses	  at	  0.05.	  	  Independent	  samples	  t-­‐tests	  were	  used	  in	  order	  to	  analyze	  the	  comparison	  of	  physical	  parameters	  (age,	  height,	  weight,	  BMI,	  and	  percent	  body	  fat)	  between	  the	  two	  groups.	  	  Comparison	  of	  VO2peak,	  peak	  workload,	  submaximal	  VO2,	  and	  submaximal	  workload	  between	  the	  two	  study	  groups	  was	  also	  performed	  using	  independent	  samples	  t-­‐tests.	  	  Paired-­‐samples	  t-­‐tests	  were	  used	  to	  compare	  the	  estimated	  submaximal	  VO2	  and	  workload	  to	  the	  actual	  submaximal	  VO2	  and	  workload	  that	  each	  study	  group	  performed	  during	  the	  acute	  aerobic	  exercise	  bout.	  	  A	  2	  x	  3	  mixed	  model	  ANOVA	  was	  used	  in	  order	  compare	  plasma	  volume	  shifts	  between	  groups	  across	  the	  three	  post-­‐exercise	  time	  periods.	  	   	   The	  markers	  of	  inflammation	  as	  well	  as	  NK	  cell	  counts	  were	  analyzed	  using	  multiple	  2	  x	  4	  mixed-­‐model	  ANOVAs.	  	  The	  two	  independent	  variables	  of	  group	  and	  time	  were	  chosen	  in	  order	  to	  compare	  the	  markers	  of	  inflammation	  and	  NK	  cell	  counts	  between	  the	  two	  groups	  across	  the	  four	  time	  periods	  throughout	  the	  study.	  	  Post-­‐hoc	  
	   57	  
analyses	  were	  run	  using	  a	  Tukey	  HSD	  test	  in	  order	  to	  see	  where	  differences	  exist	  within	  groups	  across	  time.	  	  Spearman	  rho	  correlation	  analyses	  were	  used	  to	  determine	  the	  relationship	  between	  markers	  of	  inflammation	  (independent	  variable)	  in	  relation	  to	  NK	  cell	  count	  (dependent	  variable)	  for	  both	  study	  groups.	  	  Delta	  scores	  were	  calculated	  for	  markers	  of	  inflammation	  and	  NK	  cell	  count	  from	  pre-­‐exercise	  (baseline)	  to	  each	  of	  the	  three	  post-­‐exercise	  time	  periods	  (immediate	  post,	  2	  hours	  post,	  24	  hours	  post)	  for	  both	  study	  groups.	  	  Delta	  scores	  included	  immediate	  post	  −	  baseline,	  2	  hours	  post	  −	  baseline,	  and	  24	  hours	  post	  −	  baseline.	  	  The	  delta	  scores	  for	  the	  markers	  of	  inflammation	  and	  NK	  cell	  count	  were	  used	  for	  the	  correlation	  analyses.	  	  	  	  	  	  	  	  	  	  	  





	   The	  purpose	  of	  this	  study	  was	  to	  investigate	  the	  effect	  of	  one	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise	  on	  selected	  markers	  of	  inflammation	  in	  post-­‐treatment	  breast	  cancer	  survivors.	  	  A	  secondary	  purpose	  was	  to	  examine	  the	  relationship	  between	  selected	  markers	  of	  inflammation	  and	  natural	  killer	  cell	  count.	  
	  
Subjects	  
	   This	  study	  included	  a	  total	  of	  18	  subjects:	  9	  subjects	  in	  the	  breast	  cancer	  survivor	  group	  and	  9	  subjects	  in	  the	  control	  group.	  	  Physical	  characteristics	  for	  the	  18	  subjects	  are	  presented	  in	  Table	  1.	  	  Descriptive	  statistics	  are	  presented	  as	  mean	  ±	  standard	  deviation	  (SD).	  	  Due	  to	  low	  sampling	  volume	  obtained	  during	  the	  blood	  draw	  procedure,	  2	  subjects	  in	  the	  breast	  cancer	  survivor	  group	  had	  missing	  values.	  	  One	  subject	  had	  a	  missing	  value	  immediately	  post-­‐exercise	  and	  another	  subject	  at	  2	  hours	  post-­‐exercise.	  	  Therefore	  the	  mean	  substitution	  using	  the	  percent	  change	  of	  the	  mean	  across	  time	  was	  imputed	  as	  a	  substitute	  value	  for	  these	  missing	  values.	  	  Age	  was	  the	  only	  characteristic	  for	  which	  there	  was	  a	  statistically	  significant	  difference	  between	  groups,	  where	  the	  average	  age	  of	  the	  control	  group	  was	  approximately	  9	  years	  older	  than	  the	  average	  age	  of	  the	  breast	  cancer	  survivor	  group	  (p	  =	  0.002).	  	  It	  should	  be	  noted	  that	  the	  subject	  percent	  body	  fat	  was	  very	  high	  for	  both	  groups	  (~42%).	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Table	  1.	  Subject	  characteristics	  (mean	  ±	  SD)	  Characteristic	   Breast	  Cancer	  Survivor	  Group	  (n	  =	  9)	   Control	  Group	  (n	  =	  9)	  Age	  (years)	   50	  ±	  6*	   59	  ±	  5*	  Race	  (#	  of	  women)	   Caucasian	  (8)	  African	  American	  (1)	   Caucasian	  (9)	  Height	  (cm)	   164.7	  ±	  5.8	   163.8	  ±	  5.9	  Weight	  (kg)	   76.9	  ±	  12.6	   77.7	  ±	  13.3	  Body	  Mass	  Index	  (kg/m2)	   28.4	  ±	  5.0	   28.9	  ±	  4.6	  Percent	  Body	  Fat	  (%)	   41.6	  ±	  4.5	   42.1	  ±	  4.0	  VO2peak	  (ml/kg/min)	   18.1	  ±	  2.7	   18.5	  ±	  5.1	  Peak	  Workload	  (W)	   107	  ±	  19	   106	  ±	  17	  
*p	  <	  0.05	  for	  comparing	  age	  between	  groups	  	  Table	  2.	  Cancer	  treatments	  received	  by	  breast	  cancer	  survivor	  group	  (n	  =	  9)	  Treatment	   Number	  of	  Subjects	  Receiving	  Treatment	  Surgery	  	  	   Mastectomy	  	   Lumpectomy	   	   4	  5	  Radiation	  Therapy	   9	  Chemotherapy	  	   Adriamysin	  	   Cytoxan	  	   Taxol/Taxotere	  	   Carboplatin	  
	   6	  7	  9	  3	  Hormonal	  Therapy	  	   Tamoxifen	  	   Femara	   	   5	  1	  Other	  	   Herceptin	  	   Lapatinib	  	   Bevacizumab	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Metabolic	  Responses	  
	   	   The	  submaximal	  VO2	  and	  workloads	  that	  were	  used	  during	  the	  aerobic	  exercise	  session	  are	  presented	  in	  Table	  3.	  	  Submaximal	  VO2	  and	  workload	  were	  compared	  to	  determine	  if	  there	  were	  any	  differences	  in	  exercise	  intensity	  between	  the	  groups	  during	  the	  aerobic	  exercise	  session.	  	  Estimated	  submaximal	  VO2	  and	  workload	  were	  calculated	  from	  the	  results	  of	  the	  VO2peak	  test.	  	  Actual	  submaximal	  VO2	  and	  workload	  were	  the	  results	  from	  the	  subjects	  actually	  performing	  during	  the	  exercise	  session.	  	  Estimated	  and	  actual	  submaximal	  VO2	  were	  similar	  between	  groups	  (p	  >	  0.05)	  as	  were	  estimated	  and	  actual	  submaximal	  workload	  (p	  >	  0.05).	  	  Within	  the	  breast	  cancer	  survivor	  group,	  actual	  submaximal	  VO2	  was	  significantly	  higher	  than	  estimated	  submaximal	  VO2	  (p	  =	  0.016).	  	  Within	  the	  control	  group,	  there	  was	  no	  significant	  difference	  between	  estimate	  and	  actual	  submaximal	  VO2	  (p	  =	  0.376).	  	  Table	  3.	  Metabolic	  responses	  during	  the	  submax	  aerobic	  exercise	  session	  (mean	  ±	  SD)	  Parameter	   Breast	  Cancer	  Survivor	  Group	   Control	  Group	  Estimated	  VO2	  (ml/kg/min)	   10.9	  ±	  1.6*	   11.1	  ±	  3.1	  Actual	  VO2	  (ml/kg/min)	   12.1	  ±	  1.3*	   11.1	  ±	  1.8	  Estimated	  Workload	  (W)	   63	  ±	  12	   66	  ±	  11	  Actual	  Workload	  (W)	   59	  ±	  9	   62	  ±	  11	  
*p	  <	  0.05	  for	  estimated	  vs.	  actual	  VO2	  	  	  	  
Inflammatory	  Marker	  and	  Immune	  Response	  Changes	  Descriptive	  statistics	  for	  analyses	  performed	  on	  TNF-­‐α,	  CRP,	  IL-­‐10,	  and	  NK	  cell	  counts	  are	  presented	  in	  Table	  4.	  	  There	  was	  no	  significant	  group	  by	  time	  interaction	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effect	  observed	  for	  any	  inflammatory/immune	  marker.	  	  When	  comparing	  groups,	  IL-­‐10	  was	  significantly	  lower	  in	  the	  breast	  cancer	  survivor	  group	  at	  24	  hours	  post-­‐exercise	  (p	  =	  0.044).	  	  There	  were	  no	  significant	  differences	  across	  time	  for	  any	  inflammatory	  marker	  in	  both	  groups	  (p	  >	  0.05).	  	  There	  were	  significant	  changes	  observed	  in	  NK	  cell	  counts	  across	  multiple	  study	  time	  points	  in	  both	  groups.	  	  Table	  4.	  Inflammatory	  marker	  and	  immune	  parameter	  changes	  across	  time	  (mean	  ±	  SD)	  Parameter	   Breast	  Cancer	  Survivor	  Group	   Control	  Group	  
TNF-α (pg/ml) Pre-­‐exercise	  Oh	  post-­‐exercise	  2h	  post-­‐exercise	  24h	  post-­‐exercise	  
 1.31	  ±	  0.92	  1.37	  ±	  0.91	  1.34	  ±	  0.91	  1.32	  ±	  0.91	  
	  1.59	  ±	  1.02	  1.60	  ±	  0.98	  1.55	  ±	  0.97	  1.59	  ±	  0.99	  
CRP (mg/L) 
Pre-exercise	  Oh	  post-­‐exercise	  2h	  post-­‐exercise	  24h	  post-­‐exercise	  
	  2.51	  ±	  2.70	  3.23	  ±	  3.52	  3.86	  ±	  6.02	  3.25	  ±	  4.10	  
	   3.10	  ±	  2.45	  3.50	  ±	  2.88	  3.72	  ±	  2.98	  3.22	  ±	  2.50	  IL-­‐10	  (pg/ml)	  Pre-­‐exercise	  Oh	  post-­‐exercise	  2h	  post-­‐exercise	  24h	  post-­‐exercise	  
	  6.35	  ±	  2.09	  6.00	  ±	  1.47	  6.44	  ±	  1.99	  6.25	  ±	  1.36a	  
	   16.46	  ±	  17.77	  6.88	  ±	  1.73	  10.17	  ±	  9.81	  8.55	  ±	  2.85a	  NK	  Cells	  (cells/uL)	  Pre-­‐exercise	  Oh	  post-­‐exercise	  2h	  post-­‐exercise	  24h	  post-­‐exercise	  
	   70.27	  ±	  37.86	  213.77	  ±	  131.96*	  91.76	  ±	  62.40**	  106.30	  ±	  66.78✗ 	  
	   108.88	  ±	  51.71	  357.48	  ±	  171.09*	  131.42	  ±	  92.36**	  143.93	  ±	  74.41^	  
*p	  <	  0.05	  for	  pre-­‐exercise	  vs.	  0h	  post-­‐exercise	  	  
**p	  <	  0.05	  for	  0h	  post-­‐exercise	  vs.	  2h	  post-­‐exercise	  
^p	  <	  0.05	  for	  0h	  post-­‐exercise	  vs.	  24h	  post-­‐exercise	  
✗p	  <	  0.05	  for	  2h	  post-­‐exercise	  vs.	  24h	  post-­‐exercise	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Hypotheses	  Hypothesis	  1:	  	  From	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  both	  TNF-­‐α	  and	  CRP	  will	  be	  significantly	  reduced	  in	  both	  groups.	  	  The	  results	  of	  the	  ANOVA	  models	  showed	  no	  significant	  effect	  over	  time	  for	  TNF-­‐α	  (p	  =	  0.251)	  and	  CRP	  (p	  =	  0.168),	  meaning	  there	  was	  no	  difference	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	  	  	  	  Hypothesis	  1a:	  	  From	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  IL-­‐10	  will	  be	  significantly	  increased	  in	  both	  groups.	  	  The	  results	  of	  the	  ANOVA	  model	  showed	  no	  significant	  effect	  over	  time	  for	  IL-­‐10	  (p	  =	  0.126),	  meaning	  there	  was	  no	  difference	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	  	  	  Hypothesis	  2:	  	  From	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  both	  TNF-­‐α	  and	  CRP	  will	  be	  significantly	  reduced	  in	  both	  groups.	  	  The	  results	  of	  the	  ANOVA	  models	  showed	  no	  significant	  effect	  over	  time	  for	  either	  TNF-­‐α	  (p	  =	  0.881)	  or	  CRP	  (p	  =	  0.119),	  meaning	  there	  was	  no	  difference	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	  	  	  Hypothesis	  2a:	  	  From	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  IL-­‐10	  will	  be	  significantly	  increased	  in	  both	  groups.	  	  The	  results	  of	  the	  ANOVA	  model	  showed	  no	  significant	  effect	  over	  time	  for	  IL-­‐10	  (p	  =	  0.421),	  meaning	  there	  was	  no	  difference	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	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  Hypothesis	  3:	  	  From	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  both	  TNF-­‐α	  and	  CRP	  will	  be	  significantly	  reduced	  in	  both	  groups.	  	  The	  results	  of	  the	  ANOVA	  models	  showed	  no	  significant	  effect	  over	  time	  for	  either	  TNF-­‐α	  (p	  =	  0.851)	  or	  CRP	  (p	  =	  0.229),	  meaning	  there	  was	  no	  difference	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	  	  	  Hypothesis	  3a:	  	  From	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  IL-­‐10	  will	  be	  significantly	  increased	  in	  both	  groups.	  	  The	  results	  of	  the	  ANOVA	  model	  showed	  no	  significant	  effect	  over	  time	  for	  IL-­‐10	  (p	  =	  0.221),	  meaning	  there	  was	  no	  difference	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	  	  However,	  a	  significant	  difference	  was	  found	  in	  IL-­‐10	  between	  the	  BCS	  group	  and	  the	  control	  group	  at	  24	  hours	  post-­‐exercise	  (p	  =	  0.044).	  	  As	  a	  secondary	  purpose	  (hypotheses	  4	  and	  5),	  relationships	  for	  changes	  in	  inflammatory	  markers	  and	  NK	  cell	  count	  were	  explored	  across	  each	  of	  the	  four	  time	  points	  (pre-­‐exercise,	  immediately	  post-­‐exercise,	  2	  hours	  post-­‐exercise,	  and	  24	  hours	  post-­‐exercise).	  	  No	  significant	  associations	  were	  observed	  between	  NK	  cell	  change	  and	  any	  of	  the	  inflammatory	  markers	  evaluated	  in	  this	  study	  (p	  >	  0.05).	  	  Spearman	  rho	  correlation	  coefficients	  between	  changes	  in	  inflammatory	  markers	  and	  changes	  in	  NK	  cell	  count	  in	  both	  study	  groups	  are	  presented	  in	  Table	  5	  below.	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Table	  5.	  Relationships	  between	  NK	  cell	  count	  and	  inflammatory	  markers	  	  
	  	  Hypothesis	  4:	  	  There	  will	  be	  a	  significant	  inverse	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  both	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  both	  groups.	  	  No	  significant	  relationship	  was	  found	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  TNF-­‐α	  (ρ	  =	  -­‐0.168,	  p	  =	  0.666	  and	  ρ	  =	  -­‐0.500,	  p	  =	  0.170	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  or	  CRP	  (ρ	  =	  -­‐0.084,	  p	  =	  0.831	  and	  ρ	  =	  0.317,	  p	  =	  0.406	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise.	  	  Hypothesis	  4a:	  	  There	  will	  be	  a	  significant	  inverse	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  both	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  groups.	  	  No	  significant	  relationship	  was	  found	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  TNF-­‐α	  (ρ	  =	  0.333,	  p	  =	  0.381	  and	  ρ	  =	  -­‐0.433,	  p	  =	  0.244	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  or	  CRP	  (ρ	  =	  0.267,	  p	  =	  0.488	  and	  ρ	  =	  0.067,	  p	  =	  0.865	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise.	  
	   TNF-­‐α	   CRP	   IL-­‐10	  Pre-­‐exercise	  to	  0h	  post	   BCS:	  ρ	  =	  -­‐0.168	  Con:	  ρ	  =	  -­‐0.500	   	  BCS:	  ρ	  =	  -­‐0.084	  Con:	  ρ	  =	  0.317	   BCS:	  ρ	  =	  0.333	  	  Con:	  ρ	  =	  -­‐0.550	  
Pre-­‐exercise	  to	  2h	  post	   BCS:	  ρ	  =	  0.333	  	  Con:	  ρ	  =	  -­‐0.433	   BCS:	  ρ	  =	  0.267	  Con:	  ρ	  =	  0.067	   	  BCS:	  ρ	  =	  0.250	  	  Con:	  ρ	  =	  -­‐0.633	  	  Pre-­‐exercise	  to	  24h	  post	   BCS:	  ρ	  =	  -­‐0.435	  Con:	  ρ	  =	  -­‐0.310	   BCS:	  ρ	  =	  -­‐0.400	  Con:	  ρ	  =	  -­‐0.383	   	  BCS:	  ρ	  =	  -­‐0.042	  Con:	  ρ	  =	  -­‐0.150	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  Hypothesis	  4b:	  	  There	  will	  be	  a	  significant	  inverse	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  both	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  groups.	  	  No	  significant	  relationship	  was	  found	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  TNF-­‐α	  (ρ	  =	  -­‐0.435,	  p	  =	  0.242	  and	  ρ	  =	  -­‐0.310,	  p	  =	  0.417	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  or	  CRP	  (ρ	  =	  -­‐0.400,	  p	  =	  0.286	  and	  ρ	  =	  -­‐0.383,	  p	  =	  0.308	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise.	  	  Hypothesis	  5:	  	  There	  will	  be	  a	  significant	  positive	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  both	  groups.	  	  No	  significant	  relationship	  was	  found	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  (ρ	  =	  0.333,	  p	  =	  0.381	  and	  ρ	  =	  -­‐0.550,	  p	  =	  0.125	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise.	  	  Hypothesis	  5a:	  There	  will	  be	  a	  significant	  positive	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  groups.	  	  No	  significant	  relationship	  was	  found	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  (ρ	  =	  0.250,	  p	  =	  0.516	  and	  ρ	  =	  -­‐0.633,	  p	  =	  0.067	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise.	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Hypothesis	  5b:	  	  There	  will	  be	  a	  significant	  positive	  correlation	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  groups.	  	  No	  significant	  relationship	  was	  found	  between	  changes	  in	  NK	  cell	  count	  and	  changes	  in	  IL-­‐10	  (ρ	  =	  -­‐0.042,	  p	  =	  0.915	  and	  ρ	  =	  -­‐0.150,	  p	  =	  0.700	  for	  the	  BCS	  group	  and	  control	  group,	  respectively)	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise.	  	  




DISCUSSION	  	   	   The	  purpose	  of	  the	  study	  was	  to	  examine	  the	  effect	  of	  one	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise	  on	  specific	  markers	  of	  inflammation	  in	  post-­‐treatment	  breast	  cancer	  survivors.	  	  A	  secondary	  purpose	  was	  to	  investigate	  the	  relationship	  between	  selected	  markers	  of	  inflammation	  and	  natural	  killer	  cell	  count	  to	  explore	  if	  the	  potential	  mediation	  of	  the	  immune	  response	  was	  also	  influenced	  by	  the	  inflammatory	  response	  due	  to	  exercise	  in	  breast	  cancer	  survivors.	  	   	   There	  is	  still	  much	  to	  learn	  about	  whether	  breast	  cancer	  survivors	  have	  similar	  exercise-­‐induced	  inflammatory	  responses	  when	  compared	  to	  healthy	  individuals.	  	  Currently,	  there	  are	  general	  exercise	  prescription	  guidelines	  for	  breast	  cancer	  survivors,	  and	  these	  guidelines	  are	  not	  that	  different	  from	  those	  designed	  for	  healthy	  populations	  (Schmitz	  et	  al.,	  2010).	  	  Even	  though	  breast	  cancer	  survivors	  appear	  to	  tolerate	  exercise	  and	  very	  few	  adverse	  effects	  have	  been	  reported	  due	  to	  exercise	  training,	  the	  literature	  lacks	  critical	  information	  necessary	  for	  the	  development	  of	  more	  specific	  exercise	  guidelines	  for	  breast	  cancer	  survivors.	  Questions	  regarding	  the	  immune	  and	  inflammatory	  responses	  due	  to	  acute	  and	  chronic	  exercise	  are	  among	  those	  that	  must	  be	  answered	  in	  order	  to	  advance	  the	  science	  of	  prescribing	  the	  most	  appropriate	  exercise	  interventions	  that	  can	  safely	  promote	  health	  and	  maximize	  improvements	  in	  physiological	  systems	  impacted	  by	  anti-­‐cancer	  treatment.	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   The	  majority	  of	  studies	  examining	  the	  inflammatory	  response	  due	  to	  exercise	  in	  the	  breast	  cancer	  population	  have	  been	  a	  result	  of	  long-­‐term	  exercise	  interventions.	  	  Even	  though	  studies	  evaluating	  the	  long-­‐term	  immune	  and	  inflammatory	  adaptation	  to	  exercise	  training	  are	  important,	  understanding	  an	  acute	  response	  to	  one	  bout	  of	  exercise	  is	  critical	  for	  the	  development	  of	  safer	  and	  efficacious	  exercise	  prescriptions	  for	  breast	  cancer	  survivors.	  	  In	  addition,	  continuing	  to	  explore	  the	  response	  during	  subsequent	  bouts	  of	  exercise	  (i.e.	  during	  short	  training	  microcycles)	  mimicking	  the	  current	  recommended	  exercise	  guidelines	  will	  also	  be	  essential	  for	  the	  advancement	  of	  more	  precise	  exercise	  programs	  for	  breast	  cancer	  survivors.	  	  This	  knowledge	  would	  enhance	  exercise	  prescription	  guidelines	  by	  minimizing	  the	  risk	  of	  exercise	  to	  promote	  further	  immune	  suppression	  and	  to	  better	  define	  the	  time	  course	  needed	  between	  exercise	  sessions	  for	  full	  recovery.	  	  As	  a	  result,	  a	  more	  specific	  exercise	  prescription	  would	  potentially	  assist	  breast	  cancer	  survivors	  to	  benefit	  the	  most	  from	  a	  tailored	  exercise	  training	  plan	  aimed	  to	  address	  some	  of	  the	  side-­‐effects	  of	  cancer	  treatment,	  improve	  overall	  health,	  and	  reduce	  the	  risk	  of	  a	  potential	  recurrence.	  	  	  	   	   As	  previously	  stated,	  the	  research	  in	  this	  area	  has	  been	  focused	  on	  examining	  pre-­‐	  and	  post-­‐	  levels	  of	  inflammatory	  markers	  in	  breast	  cancer	  survivors	  over	  the	  course	  of	  exercise	  training	  interventions.	  	  The	  current	  literature	  consists	  of	  mixed	  findings,	  with	  some	  studies	  resulting	  in	  positive	  changes	  in	  inflammatory	  markers	  due	  to	  exercise	  interventions	  in	  this	  population,	  while	  others	  have	  found	  no	  changes	  at	  all	  over	  time.	  	  Breast	  cancer	  survivors	  have	  been	  shown	  to	  have	  higher	  levels	  of	  circulating	  cytokines	  and	  receptors	  when	  compared	  to	  healthy	  populations,	  and	  a	  significant	  association	  has	  been	  found	  between	  increased	  concentrations	  of	  certain	  inflammatory	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markers	  and	  reduced	  overall	  survival	  (Seruga	  et	  al.,	  2008;	  Pierce	  et	  al.,	  2009a).	  	  It	  has	  been	  speculated	  that	  appropriate	  amounts	  of	  physical	  activity	  may	  promote	  the	  up-­‐regulation	  of	  anti-­‐inflammatory	  cytokines	  while	  simultaneously	  down	  regulating	  the	  expression	  of	  certain	  pro-­‐inflammatory	  cytokines	  (Battaglini	  et	  al.,	  2012).	  	  The	  exact	  mechanisms	  explaining	  this	  shift	  in	  markers	  of	  inflammation	  with	  exercise	  are	  currently	  unknown	  but	  may	  be	  occurring	  indirectly	  through	  improved	  endothelial	  function,	  reductions	  in	  body	  weight,	  or	  increased	  insulin	  sensitivity	  (Pierce	  et	  al.,	  2009b).	  	  Repeated	  bouts	  of	  exercise	  have	  resulted	  in	  cumulative	  anti-­‐inflammatory	  effects	  in	  healthy	  populations,	  but	  the	  beneficial	  effects	  of	  exercise	  in	  cancer	  survivors	  remain	  to	  be	  determined	  (Gomez	  et	  al.,	  2011).	  	  	   	   Some	  studies	  have	  found	  no	  significant	  changes	  in	  inflammatory	  markers	  over	  the	  course	  of	  training	  interventions	  consisting	  of	  various	  modes	  of	  exercise	  and	  program	  length	  (Fairey	  et	  al.,	  2005a;	  Gomez	  et	  al.	  2011;	  Hutnick	  et	  al.,	  2005).	  	  On	  the	  other	  hand,	  a	  couple	  of	  studies	  have	  found	  significant	  reductions	  in	  pro-­‐inflammatory	  markers	  over	  time,	  including	  CRP	  and	  IL-­‐6,	  as	  a	  result	  of	  training	  interventions	  (Fairey	  et	  al.,	  2005b;	  Jones	  et	  al.,	  2012).	  	  Potential	  explanations	  for	  the	  discrepancy	  on	  the	  results	  of	  the	  studies	  that	  have	  examined	  the	  effects	  of	  exercise	  training	  in	  breast	  cancer	  patients	  may	  be	  due	  to	  different	  ways	  inflammation	  was	  assessed	  (i.e.	  time	  periods),	  heterogeneity	  of	  the	  cancer	  populations	  studied,	  and	  most	  importantly,	  the	  varied	  training	  protocols	  used	  (i.e.	  different	  exercise	  intensities,	  exercise	  session	  duration,	  frequency	  of	  training,	  and	  overall	  length	  of	  the	  interventions)	  (Mills	  et	  al.,	  2000;	  Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Pedersen,	  2000).	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   A	  better	  understanding	  is	  needed	  of	  how	  exercise	  influences	  the	  inflammatory	  response	  during	  and	  after	  (recovery)	  one	  bout	  of	  acute	  exercise	  performed	  at	  different	  intensities,	  modes,	  and	  durations	  of	  exercise	  as	  well	  as	  its	  potential	  influence	  on	  the	  immune	  system	  response.	  	  Until	  this	  knowledge	  is	  obtained,	  exercise	  prescriptions	  for	  breast	  cancer	  survivors	  will	  continue	  to	  be	  general	  and	  perhaps	  not	  as	  efficacious	  and	  safe	  as	  the	  prescriptions	  could	  potentially	  be.	  	  	  	   	   This	  study	  was	  designed	  to	  begin	  the	  examination	  of	  the	  inflammatory	  response	  to	  an	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise	  in	  breast	  cancer	  survivors.	  	  Comparisons	  between	  the	  breast	  cancer	  survivor	  group	  response	  and	  a	  healthy	  sedentary	  control	  group	  was	  made	  to	  allow	  for	  this	  initial	  understanding	  of	  how	  an	  exercise	  bout	  performed	  at	  moderate	  intensity	  impacted	  the	  inflammatory	  response	  of	  a	  cancer	  patient	  in	  comparison	  to	  their	  matched	  healthy	  control	  subject.	  	  In	  the	  current	  study,	  all	  subjects	  underwent	  a	  30-­‐minute	  bout	  of	  intermittent	  exercise	  and	  had	  blood	  samples	  taken	  pre-­‐exercise,	  immediately	  post-­‐exercise,	  2	  hours	  post-­‐exercise,	  and	  24	  hours	  post-­‐exercise.	  	  Biomarkers	  of	  interest	  included	  TNF-­‐α,	  CRP,	  and	  IL-­‐10.	  	  NK	  cell	  count	  was	  also	  analyzed	  previously,	  and	  these	  values	  were	  used	  in	  the	  current	  study	  in	  order	  to	  investigate	  the	  relationship	  between	  inflammation	  and	  the	  immune	  response	  to	  exercise.	  	  Pre-­‐exercise	  to	  Immediately	  Post-­‐exercise	  	   	   Exercise	  has	  been	  shown	  to	  lower	  circulating	  levels	  of	  pro-­‐inflammatory	  markers	  while	  actually	  increasing	  levels	  of	  anti-­‐inflammatory	  markers	  in	  a	  healthy	  population	  of	  recreational	  athletes	  (Bruunsgaard,	  2005).	  	  The	  results	  of	  the	  current	  study	  were	  somewhat	  surprising	  in	  that	  there	  was	  no	  significant	  interaction	  effect	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found	  for	  each	  inflammatory	  marker	  over	  time	  in	  either	  the	  cancer	  or	  control	  group.	  Also,	  there	  was	  no	  significant	  change	  in	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  either	  group.	  	  These	  inflammatory	  markers	  responded	  differently	  than	  what	  was	  hypothesized	  where	  it	  was	  expected	  that	  TNF-­‐α	  and	  CRP	  would	  be	  significantly	  reduced	  in	  both	  groups	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise.	  	   	   Very	  few	  studies	  have	  examined	  the	  inflammatory	  response	  due	  to	  acute	  moderate-­‐intensity	  exercise,	  and	  inconsistent	  findings	  have	  been	  reported	  for	  TNF-­‐α	  and	  CRP	  (Ostrowski	  et	  al.,	  1999).	  	  The	  results	  of	  the	  current	  study	  are	  in	  agreement	  with	  previous	  studies	  where	  non-­‐significant	  changes	  in	  inflammatory	  markers	  due	  to	  acute	  moderate-­‐intensity	  exercise	  were	  observed	  (Nieman	  et	  al.,	  2005;	  Markovitch	  et	  al.,	  2008).	  	  These	  non-­‐significant	  changes	  may	  be	  due	  to	  the	  nature	  of	  the	  acute	  exercise	  bout.	  	  The	  exercise	  intensity	  and	  duration	  may	  be	  important	  factors	  in	  determining	  the	  inflammatory	  response	  to	  exercise	  (Markovitch	  et	  al.,	  2008).	  	  Also,	  the	  intermittent	  protocol	  for	  the	  current	  study	  could	  have	  resulted	  in	  a	  non-­‐significant	  inflammatory	  response	  since	  the	  subjects	  never	  underwent	  continual	  exercise.	  	  Even	  though	  TNF-­‐α	  was	  not	  significantly	  increased	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise,	  this	  marker	  followed	  a	  similar	  upward	  trend	  as	  was	  found	  for	  CRP	  in	  both	  groups.	  	  The	  current	  study’s	  sample	  size	  could	  also	  explain	  the	  lack	  of	  significant	  findings	  across	  time	  for	  the	  selected	  markers	  of	  inflammation	  due	  to	  variability	  in	  the	  values	  of	  biomarkers	  within	  groups	  analyzed	  across	  the	  study	  time	  points.	  	  As	  a	  result,	  this	  study	  may	  have	  been	  underpowered	  and	  thus	  could	  have	  affected	  the	  data’s	  statistical	  significance.	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   Since	  there	  was	  no	  significant	  interaction	  effect	  observed	  in	  TNF-­‐α	  (p	  =	  0.407)	  or	  CRP	  (p	  =	  0.409)	  in	  both	  groups	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise,	  the	  two	  groups	  underwent	  similar	  changes	  in	  levels	  of	  these	  inflammatory	  markers.	  	  An	  interesting	  finding	  of	  this	  study	  was	  that	  the	  control	  group	  had	  higher	  resting	  levels	  at	  pre-­‐exercise	  and	  immediately	  post-­‐exercise	  of	  both	  TNF-­‐α	  and	  CRP	  when	  compared	  to	  the	  breast	  cancer	  survivor	  group.	  	  In	  healthy	  individuals,	  elevated	  levels	  of	  CRP	  may	  be	  associated	  with	  increased	  body	  fat	  and	  sedentary	  lifestyles	  (Pierce	  et	  al.,	  2009b).	  	  Since	  the	  control	  group	  consisted	  of	  healthy	  women	  who	  were	  sedentary,	  this	  may	  provide	  a	  possible	  explanation	  for	  why	  they	  had	  higher	  resting	  values.	  	  However,	  the	  majority	  of	  the	  subjects	  in	  the	  breast	  cancer	  survivor	  group	  were	  also	  sedentary,	  and	  both	  groups	  had	  similar	  VO2peak	  values.	  	  The	  differences	  in	  TNF-­‐α	  and	  CRP	  between	  groups	  at	  both	  pre-­‐exercise	  and	  immediately	  post-­‐exercise	  were	  not	  significant,	  but	  these	  findings	  came	  as	  a	  surprise	  since	  breast	  cancer	  survivors	  have	  been	  shown	  to	  have	  higher	  resting	  concentrations	  of	  certain	  pro-­‐inflammatory	  markers,	  such	  as	  TNF-­‐α	  and	  CRP	  (Pierce	  et	  al.,	  2009a;	  Seruga	  et	  al.,	  2008).	  	   	   The	  anti-­‐inflammatory	  cytokine	  IL-­‐10	  was	  not	  significantly	  changed	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise	  in	  either	  group	  (p	  =	  0.126).	  	  There	  was	  also	  no	  significant	  group	  by	  time	  interaction	  effect	  (p	  =	  0.154)	  observed	  even	  though	  the	  control	  group	  had	  more	  than	  twice	  the	  concentration	  of	  IL-­‐10	  in	  pg/ml	  at	  pre-­‐exercise	  compared	  to	  the	  breast	  cancer	  survivors.	  	  This	  was	  most	  likely	  due	  to	  the	  variability	  in	  the	  IL-­‐10	  data	  for	  both	  groups.	  	  Some	  duplicate	  determinates	  had	  high	  variability	  and	  therefore,	  the	  lower	  singlet	  values	  of	  the	  duplicates,	  more	  in	  line	  with	  the	  rest	  of	  the	  samples,	  were	  selected	  for	  statistical	  analyses.	  	  Exercise	  has	  been	  shown	  to	  produce	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acute	  increases	  in	  various	  anti-­‐inflammatory	  mediators	  (Kasapis	  and	  Thompson,	  2005).	  	  However,	  the	  current	  study	  resulted	  in	  a	  non-­‐significant	  anti-­‐inflammatory	  response	  due	  to	  exercise	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise.	  	  Both	  groups	  in	  this	  study	  surprisingly	  experienced	  a	  downward	  trend	  in	  IL-­‐10	  levels	  from	  pre-­‐exercise	  to	  immediately	  post-­‐exercise,	  meaning	  there	  was	  no	  anti-­‐inflammatory	  response	  experienced	  as	  a	  result	  of	  the	  acute	  bout	  of	  moderate	  intensity	  exercise.	  Pre-­‐exercise	  to	  2	  Hours	  Post-­‐exercise	  	   There	  was	  no	  significant	  effect	  over	  time	  for	  either	  TNF-­‐α	  (p	  =	  0.881)	  or	  CRP	  (p	  =	  0.119)	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  control	  group.	  	  Even	  though	  the	  results	  did	  not	  match	  what	  was	  hypothesized,	  a	  non-­‐significant	  change	  in	  inflammatory	  markers	  was	  somewhat	  expected	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  based	  on	  the	  current	  research	  literature	  in	  healthy	  populations.	  	  There	  was	  no	  interaction	  effect	  for	  TNF-­‐α	  (p	  =	  0.506)	  and	  CRP	  (p	  =	  0.551)	  between	  the	  groups	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise,	  indicating	  both	  groups	  responded	  similarly.	  	  	  Several	  studies	  have	  examined	  the	  effect	  of	  an	  acute	  bout	  of	  moderate	  intensity	  exercise	  on	  the	  inflammatory	  response	  in	  healthy	  populations.	  	  These	  studies	  have	  found	  non-­‐significant	  changes	  in	  the	  levels	  of	  certain	  inflammatory	  markers	  up	  to	  several	  hours	  post-­‐exercise	  (Nieman	  et	  al.,	  2005;	  Markovitch	  et	  al.,	  2008).	  	  It	  appears	  that	  moderate	  intensity	  exercise	  may	  not	  stimulate	  a	  prolonged	  inflammatory	  response	  such	  as	  that	  found	  with	  more	  vigorous	  activities	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Markovitch	  et	  al.,	  2008).	  	  It	  should	  be	  noted,	  however,	  that	  CRP	  continued	  to	  trend	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upward	  in	  both	  groups	  at	  2	  hours	  post-­‐exercise.	  	  This	  could	  be	  an	  indication	  that	  levels	  of	  certain	  pro-­‐inflammatory	  markers	  continually	  increase	  after	  acute	  exercise.	  	  	   IL-­‐10	  concentration	  was	  not	  significantly	  changed	  over	  time	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  in	  either	  the	  breast	  cancer	  survivor	  group	  or	  control	  group	  (p	  =	  0.421).	  	  There	  was	  also	  no	  significant	  interaction	  effect	  observed	  between	  the	  two	  study	  groups	  over	  time	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise	  (p	  =	  0.408).	  	  Along	  with	  the	  changes	  in	  TNF-­‐α	  and	  CRP,	  both	  groups	  exhibited	  similar	  changes	  in	  IL-­‐10	  at	  2	  hours	  post-­‐exercise.	  	  The	  current	  study	  may	  be	  scrutinized	  in	  the	  handling	  of	  subject	  blood	  samples.	  	  Numerous	  freeze-­‐thaw	  cycles	  have	  been	  shown	  to	  result	  in	  the	  damage	  of	  antibodies	  or	  antigens	  in	  blood	  samples	  (Zhou	  et	  al.,	  2010).	  	  Even	  though	  there	  were	  several	  freeze-­‐thaw	  cycles,	  this	  process	  was	  performed	  universally	  for	  all	  samples	  in	  both	  groups.	  	   It	  appeared	  that	  the	  moderate	  intensity	  intermittent	  bout	  of	  acute	  exercise	  was	  insufficient	  in	  inducing	  a	  significant	  pro-­‐	  or	  anti-­‐inflammatory	  response	  up	  until	  2	  hours	  post-­‐exercise.	  	  Even	  though	  there	  were	  non-­‐significant	  changes,	  specific	  inflammatory	  markers,	  such	  as	  CRP,	  continued	  to	  increase	  up	  until	  the	  2	  hour	  post-­‐exercise	  assessment	  time.	  	  This	  continual	  increasing	  trend	  in	  CRP	  was	  not	  clinically	  significant	  with	  the	  minute	  change	  observed	  up	  until	  2	  hours	  post-­‐exercise.	  	  Therefore,	  it	  appears	  that	  after	  2	  hours	  post	  moderate	  intensity	  intermittent	  exercise,	  the	  non-­‐increase	  in	  the	  systemic	  inflammatory	  response	  represented	  by	  CPR,	  may	  indicate	  that	  the	  acute	  bout	  of	  exercise	  was	  not	  tasking	  the	  subjects	  enough	  to	  produce	  clinically	  relevant	  levels	  of	  inflammation.	  	  The	  breast	  cancer	  survivors	  did	  respond	  similarly	  to	  the	  healthy	  sedentary	  controls	  from	  pre-­‐exercise	  to	  2	  hours	  post-­‐exercise,	  suggesting	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they	  may	  recover	  in	  a	  comparable	  manner	  to	  acute	  exercise	  as	  their	  healthy	  counterparts	  up	  until	  2	  hours	  post-­‐exercise.	  Pre-­‐exercise	  to	  24	  Hours	  Post-­‐exercise	  	   	   There	  was	  no	  significant	  effect	  over	  time	  for	  either	  TNF-­‐α	  (p	  =	  0.851)	  or	  CRP	  (p	  =	  0.229)	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  the	  breast	  cancer	  survivor	  group	  and	  the	  healthy	  control	  group.	  	  The	  results	  observed	  at	  this	  point	  in	  time	  support	  the	  fact	  that	  the	  moderate	  intensity	  exercise	  bout	  may	  not	  have	  been	  enough	  stimulus	  to	  cause	  a	  prolonged	  response	  in	  inflammatory	  markers.	  	  For	  both	  groups	  TNF-­‐α	  levels	  were	  very	  similar	  at	  24	  hours	  post-­‐exercise	  compared	  to	  the	  subjects’	  pre-­‐exercise	  resting	  values.	  In	  the	  healthy	  controls,	  CRP	  concentration	  in	  the	  blood	  essentially	  remained	  the	  same	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  while	  CRP	  levels	  in	  the	  breast	  cancer	  survivor	  group	  remained	  elevated	  at	  24	  hours	  post-­‐exercise	  when	  compared	  to	  pre-­‐exercise	  levels.	  	  However,	  CRP	  concentration	  did	  decrease	  from	  2	  hours	  to	  24	  hours	  post-­‐exercise,	  indicating	  a	  full	  recovery	  was	  taking	  place	  in	  the	  breast	  cancer	  survivors	  due	  to	  the	  acute	  bout	  of	  exercise.	  	  There	  was	  also	  no	  interaction	  effect	  between	  the	  two	  groups	  over	  time	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  both	  TNF-­‐α	  (p	  =	  0.821)	  and	  CRP	  (p	  =	  0.379).	  	  These	  results	  imply	  that	  both	  groups	  had	  similar	  minute	  changes	  in	  the	  concentrations	  of	  TNF-­‐α	  and	  CRP	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise.	  	  	   	   No	  significant	  difference	  was	  found	  for	  IL-­‐10	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  in	  either	  group	  (p	  =	  0.221).	  	  In	  addition,	  there	  was	  no	  significant	  interaction	  effect	  observed	  between	  the	  two	  groups	  from	  pre-­‐exercise	  to	  24	  hours	  post-­‐exercise	  (p	  =	  0.233).	  	  IL-­‐10	  responded	  similarly	  compared	  to	  the	  pro-­‐inflammatory	  markers	  in	  that	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all	  of	  these	  markers	  were	  not	  significantly	  altered	  over	  time	  up	  until	  24	  hours	  post-­‐exercise	  in	  both	  study	  groups.	  	  However,	  there	  was	  a	  significant	  difference	  found	  in	  IL-­‐10	  between	  the	  breast	  cancer	  survivor	  group	  and	  the	  healthy	  control	  group	  at	  24	  hours	  post-­‐exercise.	  	  The	  healthy	  control	  subjects	  had	  significantly	  higher	  levels	  of	  IL-­‐10	  compared	  to	  the	  breast	  cancer	  survivors	  at	  24	  hours	  post-­‐exercise	  (p	  =	  0.044).	  	  This	  finding	  may	  be	  important	  when	  examining	  the	  more	  prolonged	  anti-­‐inflammatory	  response	  due	  to	  exercise	  in	  breast	  cancer	  survivors.	  	  It	  is	  known	  that	  breast	  cancer	  survivors,	  along	  with	  the	  cancer	  population	  in	  general,	  have	  lower	  concentrations	  of	  certain	  anti-­‐inflammatory	  markers	  such	  as	  IL-­‐10	  compared	  to	  healthy	  populations	  of	  a	  similar	  age	  (Seruga	  et	  al.,	  2008).	  	  The	  current	  finding	  may	  be	  misinterpreted	  that	  a	  longer	  recovery	  is	  needed	  from	  an	  acute	  bout	  of	  exercise	  for	  breast	  cancer	  survivors.	  	  Even	  though	  there	  was	  a	  statistically	  significant	  difference	  between	  the	  study	  groups,	  the	  breast	  cancer	  survivors	  returned	  to	  their	  pre-­‐exercise	  resting	  level	  of	  IL-­‐10	  at	  24	  hours	  post-­‐exercise.	  	  It	  is	  possible	  that	  this	  population	  has	  lower	  resting	  levels	  of	  anti-­‐inflammatory	  markers	  compared	  to	  healthy	  populations,	  but	  they	  respond	  similarly	  to	  an	  acute	  bout	  of	  moderate	  intensity	  exercise.	  	  There	  were	  no	  other	  significant	  differences	  observed	  between	  the	  two	  groups	  at	  any	  other	  time	  point	  in	  the	  study	  for	  any	  inflammatory	  markers.	  	  This	  makes	  it	  apparent	  that	  the	  breast	  cancer	  survivor	  group	  responded	  similarly	  as	  the	  healthy	  control	  group	  to	  the	  exercise	  bout.	  	  	  	  	  	  	  	   	   Since	  there	  were	  no	  differences	  between	  the	  two	  groups	  in	  CRP	  (p	  =	  0.918)	  and	  TNF-­‐alpha	  (p	  =	  0.591)	  over	  time,	  breast	  cancer	  survivors	  may	  potentially	  have	  a	  similar	  pro-­‐inflammatory	  response	  to	  exercise	  as	  their	  healthy	  counterparts.	  This	  is	  exciting	  because	  breast	  cancer	  survivors	  may	  be	  able	  to	  respond	  similarly	  and	  undergo	  exercise	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prescriptions	  designed	  for	  healthy	  populations.	  	  This	  study	  lends	  support	  to	  the	  idea	  that	  current	  exercise	  prescriptions	  designed	  for	  healthy	  populations	  and	  used	  for	  breast	  cancer	  survivors	  may	  be	  safe	  and	  be	  able	  to	  promote	  benefits.	  	  However,	  these	  results	  should	  be	  analyzed	  with	  caution	  and	  further	  research	  needs	  to	  be	  done	  to	  explore	  the	  current	  study’s	  findings.	  Relationship	  between	  markers	  of	  inflammation	  and	  the	  immune	  response	  	   	   There	  is	  a	  known	  relationship	  between	  markers	  of	  inflammation	  and	  immune	  parameters.	  	  Inflammatory	  markers	  are	  considered	  the	  principal	  mediators	  of	  communication	  between	  cells	  of	  the	  immune	  system,	  functioning	  as	  key	  contributors	  to	  immunity	  and	  inflammation	  (Abbas,	  2005).	  	  Cytokines	  are	  released	  from	  immune	  cells	  in	  a	  signaling	  fashion,	  and	  they	  have	  strong	  roles	  in	  the	  up-­‐regulation	  of	  particular	  immune	  parameters	  (Pedersen,	  2000).	  	  These	  soluble	  proteins	  allow	  communication	  between	  immune	  cells	  with	  coordination	  of	  inflammatory	  responses	  (Zhou	  et	  al.,	  2010).	  	  	  	   	   The	  current	  study	  resulted	  in	  no	  significant	  relationships	  found	  between	  changes	  in	  NK	  cell	  count	  and	  inflammatory	  markers	  across	  time.	  	  This	  was	  an	  unexpected	  finding.	  	  There	  were	  significant	  changes	  observed	  in	  NK	  cell	  count	  over	  time	  in	  both	  groups,	  but	  there	  were	  no	  corresponding	  changes	  in	  the	  markers	  of	  inflammation.	  	  The	  lack	  of	  associations	  between	  markers	  of	  inflammation	  and	  the	  immune	  response	  in	  this	  study	  may	  be	  attributed	  in	  part	  to	  the	  intensity	  and	  nature	  of	  the	  exercise	  used.	  	  Since	  breast	  cancer	  patients	  were	  not	  able	  to	  perform	  30	  minutes	  of	  moderate	  intensity	  aerobic	  exercise	  uninterruptedly	  in	  a	  pilot	  study	  conducted	  prior	  to	  the	  beginning	  of	  the	  study,	  the	  adoption	  of	  the	  intermittent	  nature	  of	  the	  exercise	  was	  an	  attempt	  to	  reproduce	  the	  duration	  and	  intensity	  known	  to	  provoke	  an	  immune	  and	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inflammatory	  response.	  	  Considering	  the	  acute	  bout	  of	  exercise	  was	  not	  continuous,	  the	  recurrent	  1.5	  minutes	  of	  rest	  for	  every	  3	  minutes	  of	  exercise	  could	  have	  lead	  to	  the	  non-­‐significant	  inflammatory	  response	  observed,	  and	  therefore,	  resulted	  in	  the	  lack	  of	  mediation	  of	  the	  immune	  response.	  	  	  	   	   A	  major	  finding	  of	  this	  investigation	  was	  that	  acute	  moderate	  intermittent	  exercise	  led	  to	  inflammatory	  and	  NK	  cell	  count	  responses	  that	  were	  similar	  in	  both	  study	  groups,	  and	  that	  neither	  group	  experienced	  significant	  post-­‐exercise	  values	  in	  inflammation	  or	  NK	  cell	  count	  relative	  to	  pre-­‐exercise	  values.	  	  This	  is	  an	  important	  finding	  as	  it	  suggests	  this	  particular	  physical	  activity,	  which	  is	  commonly	  used	  in	  prescriptive	  exercise	  for	  breast	  cancer	  survivors,	  caused	  a	  typical	  response	  as	  previously	  seen	  in	  other	  healthy	  individuals	  (Ostrowski	  et	  al.,	  2003;	  Steensberg	  et	  al.,	  2003;	  Nieman	  et	  al.,	  2005).	  	  Inflammatory	  and	  immune	  response	  due	  to	  an	  acute	  bout	  of	  exercise	  	  	   	   The	  mechanisms	  through	  which	  physical	  activity	  influences	  the	  inflammatory	  process	  are	  not	  well	  understood	  (Ford,	  2002).	  	  Potential	  mechanisms	  include:	  reductions	  in	  body	  mass,	  positive	  changes	  in	  lipid	  and	  glycemic	  profiles,	  and	  improved	  endothelial	  function	  (Markovitch	  et	  al.,	  2008;	  Pierce	  et	  al.,	  2009b).	  	  The	  results	  seen	  in	  the	  current	  study	  are	  most	  likely	  due	  to	  the	  exercise	  session	  itself,	  since	  there	  were	  similar	  non-­‐significant	  changes	  found	  in	  both	  groups.	  	  	  	   	   While	  some	  previous	  studies	  have	  found	  moderate-­‐intensity	  exercise	  to	  elicit	  changes	  in	  certain	  inflammatory	  markers,	  other	  studies	  have	  found	  no	  effect	  (Mills	  et	  al.,	  2000;	  Nieman	  et	  al.,	  2005;	  Plaisance	  et	  al.,	  2007).	  	  There	  are	  several	  possible	  explanations	  for	  these	  variable	  results	  on	  cytokines	  response	  in	  relation	  to	  exercise	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including:	  1)	  the	  intensity	  and	  duration	  of	  the	  exercise,	  as	  well	  as	  the	  type	  of	  physical	  activity;	  2)	  the	  specificity	  and	  the	  sensitivity	  of	  the	  assays	  used	  in	  particular	  studies	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000;	  Pedersen,	  2000).	  	  The	  current	  study	  resulted	  in	  no	  significant	  inflammatory	  marker	  changes	  in	  the	  breast	  cancer	  survivor	  group	  and	  the	  healthy	  control	  group,	  so	  it	  appeared	  that	  both	  groups	  responded	  similarly	  to	  the	  acute	  bout	  of	  moderate	  intensity	  intermittent	  exercise.	  	  Since	  moderate	  intensity	  exercise	  was	  not	  able	  to	  significantly	  change	  inflammatory	  markers	  in	  both	  groups,	  there	  may	  be	  a	  specific	  intensity	  or	  duration	  threshold	  that	  must	  be	  achieved	  in	  order	  to	  elicit	  an	  acute	  change	  in	  biomarkers	  such	  as	  TNF-­‐α,	  CRP,	  and	  IL-­‐10	  in	  breast	  cancer	  survivors	  and	  sedentary	  healthy	  women.	  	  The	  magnitude	  of	  the	  increases	  found	  in	  markers	  of	  inflammation	  may	  be	  closely	  related	  to	  the	  duration	  of	  the	  exercise	  (Pedersen	  and	  Hoffman-­‐Goetz,	  2000).	  	  It	  is	  possible	  that	  longer	  durations	  of	  exercise	  may	  produce	  a	  more	  significant	  inflammatory	  response	  (Pedersen,	  2000).	  	  	  	  	   Exercise	  has	  the	  ability	  to	  produce	  acute	  and	  long-­‐term	  increases	  in	  various	  anti-­‐inflammatory	  mediators,	  and	  several	  studies	  have	  found	  increases	  in	  anti-­‐inflammatory	  markers	  after	  acute	  bouts	  of	  exercise	  (Kasapis	  and	  Thompson,	  2005;	  Starkie	  et	  al.,	  2003).	  	  These	  anti-­‐inflammatory	  effects	  of	  acute	  exercise	  are	  very	  prominent	  in	  studies	  examining	  vigorous	  intensity	  exercise	  as	  well	  as	  longer	  durations	  of	  exercise	  in	  healthy	  populations	  (Starkie	  et	  al.,	  2003;	  Petersen	  and	  Pedersen,	  2005).	  	  The	  current	  study	  did	  not	  result	  in	  the	  up-­‐regulation	  of	  anti-­‐inflammatory	  pathways,	  such	  as	  a	  positive	  IL-­‐10	  response	  elicited	  by	  an	  acute	  bout	  of	  exercise	  that	  has	  been	  thoroughly	  reported	  in	  the	  literature.	  	  This	  could	  be	  due	  to	  cancer	  treatments	  suppressing	  the	  inflammatory	  response	  in	  the	  breast	  cancer	  survivors.	  	  The	  reason	  for	  this	  response	  not	  occurring	  in	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the	  current	  study	  may	  be	  speculated	  to	  be	  a	  result	  of	  the	  acute	  bout	  of	  exercise	  implemented,	  especially	  since	  both	  groups	  experienced	  a	  similar	  non-­‐significant	  inflammatory	  response.	  	  It	  may	  be	  that	  moderate	  intensity	  exercise	  is	  simply	  not	  demanding	  enough	  to	  stimulate	  the	  anti-­‐inflammatory	  effects	  commonly	  seen	  at	  more	  vigorous	  intensities	  of	  exercise.	  	  Markovitch	  et	  al.	  (2008)	  similarly	  found	  that	  acute	  moderate	  intensity	  exercise	  had	  no	  effect	  on	  pro-­‐	  or	  anti-­‐inflammatory	  responses.	  	  The	  results	  from	  this	  study	  may	  suggest	  that	  the	  long-­‐term	  anti-­‐inflammatory	  effects	  that	  were	  previously	  reported	  with	  exercise	  of	  moderate-­‐intensity	  must	  be	  explained	  by	  something	  other	  than	  a	  net	  anti-­‐inflammatory	  response	  to	  each	  exercise	  bout	  (Markovitch	  et	  al.,	  2008).	  	  Other	  mechanisms	  such	  as	  changes	  in	  body	  mass,	  lipid	  profiles,	  and	  glycemic	  profiles	  have	  been	  shown	  to	  be	  responsible	  for	  changes	  in	  inflammatory	  markers	  due	  to	  exercise	  over	  time	  (Okita	  et	  al.,	  2004;	  Shojaee-­‐Moradie	  et	  al.,	  2007).	  	  In	  addition,	  there	  may	  be	  a	  certain	  threshold	  that	  needs	  to	  be	  met	  during	  exercise	  in	  order	  to	  stimulate	  a	  significant	  change	  in	  markers	  of	  inflammation.	  	  Once	  again,	  this	  is	  currently	  all	  speculation,	  and	  more	  research	  needs	  to	  be	  done	  in	  order	  to	  support	  or	  refute	  these	  findings.	  	   	   The	  intermittent	  nature	  of	  the	  acute	  bout	  of	  moderate	  intensity	  exercise	  implemented	  in	  the	  current	  study	  could	  have	  contributed	  to	  non-­‐significant	  changes	  in	  inflammatory	  markers	  across	  time.	  	  A	  discontinuous	  exercise	  protocol	  was	  used	  to	  ensure	  that	  all	  subjects	  would	  be	  capable	  of	  completing	  the	  exercise	  session,	  and	  subjects	  underwent	  30	  minutes	  of	  exercise	  in	  a	  43.5-­‐minute	  period,	  alternating	  ten	  3-­‐minute	  intervals	  of	  exercise	  with	  1.5	  minutes	  of	  rest.	  	  Since	  the	  acute	  bout	  was	  not	  continuous	  moderate	  intensity,	  this	  could	  have	  lead	  to	  a	  further	  delay	  in	  a	  significant	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inflammatory	  response.	  	  	   NK	  cell	  count	  was	  significantly	  changed	  as	  measured	  conclusively	  in	  both	  groups.	  	  The	  magnitude	  of	  change	  in	  both	  NK	  cell	  count	  and	  inflammatory	  markers	  was	  similar	  between	  groups.	  	  This	  suggests	  that	  the	  exercise	  bout	  elicited	  a	  response	  in	  the	  breast	  cancer	  survivors	  that	  paralleled	  the	  healthy	  controls	  who	  had	  never	  experienced	  cancer	  treatment.	  	  However,	  no	  significant	  changes	  were	  observed	  when	  values	  were	  compared	  back	  to	  baseline	  in	  any	  of	  the	  inflammatory	  markers.	  	  The	  intensity	  and/or	  duration	  of	  the	  acute	  exercise	  bout	  may	  be	  considered	  the	  major	  reason	  for	  these	  non-­‐significant	  changes	  occurring	  in	  the	  current	  study,	  and	  a	  specific	  threshold	  may	  need	  to	  be	  obtained	  in	  order	  to	  stimulate	  the	  inflammatory	  response.	  	  Interestingly,	  the	  majority	  of	  studies	  finding	  significant	  changes	  over	  time	  have	  included	  recreationally	  active	  healthy	  populations	  (Ostrowski	  et	  al.,	  1999;	  Starkie	  et	  al.,	  2003;	  Steensberg	  et	  al.,	  2003;	  Kasapis	  and	  Thompson,	  2005).	  	  This	  study	  had	  a	  healthy	  sedentary	  population	  as	  the	  control	  group	  with	  similar	  activity	  levels	  to	  the	  breast	  cancer	  survivors.	  	  The	  mediation	  of	  the	  immune	  system	  response	  due	  to	  exercise	  may	  not	  be	  attributable	  to	  markers	  of	  inflammation,	  especially	  at	  lower	  intensities	  of	  exercise.	  	  In	  addition,	  the	  acute	  inflammatory	  response	  commonly	  seen	  as	  a	  result	  of	  exercise	  may	  occur	  to	  a	  lesser	  extent	  in	  sedentary	  individuals.	  	  In	  order	  to	  improve	  immune	  response	  and	  receive	  positive	  anti-­‐inflammatory	  benefits	  from	  exercise,	  more	  than	  one	  acute	  bout	  may	  be	  needed.	  	  Multiple	  acute	  bouts	  may	  be	  more	  likely	  to	  stimulate	  the	  inflammatory	  mediation	  of	  the	  immune	  response	  in	  sedentary	  populations.	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Conclusion	  	   In	  a	  group	  of	  breast	  cancer	  survivors	  and	  healthy	  controls,	  no	  significant	  changes	  were	  observed	  between	  groups	  across	  time	  due	  to	  an	  acute	  bout	  of	  moderate	  intensity	  exercise	  in	  levels	  of	  TNF-­‐α,	  CRP,	  and	  IL-­‐10.	  	  Both	  groups	  responded	  similarly	  to	  the	  acute	  bout	  of	  exercise	  in	  regards	  to	  markers	  of	  inflammation	  and	  NK	  cell	  count,	  indicating	  there	  is	  potential	  that	  exercise	  prescriptions	  for	  healthy	  populations	  may	  be	  able	  to	  be	  implemented	  for	  breast	  cancer	  survivors.	  	  There	  were	  significant	  changes	  over	  time	  in	  the	  immune	  parameter	  of	  NK	  cell	  count	  in	  both	  groups,	  while	  inflammatory	  markers	  in	  these	  groups	  did	  not	  significantly	  change.	  	  The	  bout	  of	  acute	  exercise	  appeared	  to	  be	  less	  intense	  than	  needed	  to	  stimulate	  the	  mediation	  of	  the	  immune	  response	  by	  inflammatory	  markers.	  	  Whether	  this	  is	  due	  to	  the	  intensity	  or	  duration,	  we	  currently	  do	  not	  know.	  	  The	  exact	  mechanisms	  explaining	  the	  changes	  in	  both	  the	  inflammatory	  and	  immune	  response	  to	  acute	  exercise	  are	  currently	  not	  well	  understood.	  	  Further	  research	  needs	  to	  be	  done	  in	  order	  to	  support	  or	  refute	  this	  study’s	  findings.	  	  Recommendations	  for	  future	  research	  	   Based	  on	  the	  results	  of	  the	  current	  study,	  future	  studies	  should	  include	  larger	  sample	  sizes	  with	  more	  time	  points	  for	  the	  analysis	  of	  the	  inflammatory	  response	  due	  to	  acute	  exercise.	  	  Increasing	  the	  number	  of	  blood	  sampling	  time	  points	  would	  allow	  a	  better	  understanding	  of	  the	  recovery	  process	  due	  to	  exercise,	  but	  may	  not	  be	  very	  practical.	  	  Future	  research	  should	  focus	  on	  whether	  a	  certain	  intensity	  or	  duration	  threshold	  is	  needed	  to	  elicit	  a	  significant	  inflammatory	  response	  from	  an	  acute	  bout	  of	  exercise,	  since	  it	  has	  been	  commonly	  reported	  that	  lower	  levels	  of	  exercise	  have	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resulted	  in	  non-­‐significant	  changes	  in	  the	  inflammatory	  response	  in	  both	  healthy	  and	  clinical	  populations.	  	  Different	  durations	  and	  intensities	  of	  acute	  exercise	  should	  be	  compared	  in	  order	  to	  see	  if	  the	  bout	  of	  exercise	  itself	  is	  a	  limiting	  factor	  in	  changes	  in	  markers	  of	  inflammation	  in	  breast	  cancer	  survivors.	  	  Also,	  investigation	  of	  cumulative	  acute	  bouts	  of	  exercise	  versus	  single	  acute	  bouts	  of	  exercise	  should	  be	  explored.	  	  Since	  there	  is	  a	  known	  anti-­‐inflammatory	  effect	  that	  occurs	  with	  chronic	  exercise	  training	  in	  healthy	  physically	  active	  individuals,	  it	  would	  be	  interesting	  to	  investigate	  the	  effects	  of	  multiple	  acute	  bouts	  of	  exercise	  in	  cancer	  patients.	  	  A	  training	  program	  reproducing	  current	  exercise	  guidelines	  for	  cancer	  patients	  could	  be	  carried	  out	  to	  see	  if	  in	  fact	  the	  cumulative	  effects	  of	  training	  is	  what	  produces	  a	  favorable	  response	  in	  relation	  to	  inflammation	  (i.e.	  increase	  in	  anti-­‐inflammatory	  markers).	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APPENDIX	  A:	  SAMPLE	  SIZE	  CALCULATION	  Sample	  size	  calculation	  using	  PS	  software	  program,	  2009	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